id,title,description_questions,query,included_studies
43,Prevalence of Differentiated Thyroid Cancer in Autopsy Studies Over Six Decades: A Meta-Analysis,Autopsy studies for lung cancer,"((""Thyroid Neoplasms""[MeSH] OR ""Adenocarcinoma, Follicular""[MeSH] OR ""Adenocarcinoma, Papillary""[MeSH] OR OPTC OR ((Thyroid[tiab] OR Follicular[tiab] OR Papillary[tiab] OR hurtle cell[tiab]) AND (cancer[tiab] OR cancers[tiab] OR carcinoma[tiab] OR carcinomas[tiab] OR Adenocarcinoma[tiab] OR Adenocarcinomas[tiab] OR neoplasm[tiab] OR neoplasms[tiab] OR nodule[tiab] OR nodules[tiab] OR tumor[tiab] OR tumour[tiab] OR Tumors[tiab] OR Tumours[tiab] OR cyst[tiab] OR cysts[tiab]))) AND (""Autopsy""[MeSH] OR ""Autopsy""[tiab] OR ""Autopsies""[tiab] OR ""Postmortem""[tiab] OR Post-mortem[tiab] OR “step-sectioned”[tiab] OR “step sectioned”[tiab] OR  (Post[tiab] AND mortem[tiab])) AND (""Prevalence""[MeSH] OR ""Prevalence""[tiab] OR ""Prevalences""[tiab] OR Incidence[tiab] OR Epidemiology[tiab] OR Epidemiological[tiab] OR Frequency[tiab] OR Detected[tiab]) AND (""Incidental Findings""[MeSH] OR Incidental[tiab] OR Unsuspected[tiab] OR Discovery[tiab] OR Discoveries[tiab] OR Findings[tiab] OR Finding[tiab] OR Occult[tiab] OR Hidden[tiab] OR Latent[tiab] OR Consecutive[tiab]))","17159249, 2302665, 6504772, 6514426, 2270881, 2676140, 6697317, 14155218, 8165018, 3561602, 10420443, 3731026, 1182663, 2408737, 14952481, 14349472, 3378788, 15753675, 3389346, 8508367, 12017327, 13263417, 11478265, 3967189, 2736500, 7162868, 4474057, 977240, 7239870, 5915940, 445361, 15742259, 21464719, 1437838"
96,Prevalence of Differentiated Thyroid Cancer in Autopsy Studies Over Six Decades: A Meta-Analysis,Incidental Thyroid Cancers after Autopsy: a systematic review and meta-analysis,"(""Thyroid Neoplasms""[Mesh] OR ""Adenocarcinoma, Follicular""[Mesh] OR ""Adenocarcinoma, Papillary""[Mesh] OR OPTC OR ((Thyroid[tiab] OR Follicular[tiab] OR Papillary[tiab] OR hurtle cell[tiab]) AND (cancer[tiab] OR cancers[tiab] OR carcinoma[tiab] OR carcinomas[tiab] OR Adenocarcinoma[tiab] OR Adenocarcinomas[tiab] OR neoplasm[tiab] OR neoplasms[tiab] OR nodule[tiab] OR nodules[tiab] OR tumor[tiab] OR tumour[tiab] OR Tumors[tiab] OR Tumours[tiab] OR cyst[tiab] OR cysts[tiab]))) AND (""Autopsy""[Mesh] OR ""Autopsy""[tiab] OR ""Autopsies""[tiab] OR ""Postmortem""[tiab] OR Post-mortem[tiab] OR (Post[tiab] AND mortem[tiab])) AND (""Prevalence""[Mesh] OR ""Epidemiology""[Mesh] OR ""Prevalence""[tiab] OR ""Prevalences""[tiab] OR Epidemiology[tiab] OR Epidemiological[tiab] OR Frequency[tiab]) AND (""Incidental Findings""[Mesh] OR Incidental[tiab] OR Unsuspected[tiab] OR Discovery[tiab] OR Discoveries[tiab] OR Findings[tiab] OR Finding[tiab] OR Occult[tiab] OR Hidden[tiab]) ","17159249, 2302665, 6504772, 6514426, 2270881, 2676140, 6697317, 14155218, 8165018, 3561602, 10420443, 3731026, 1182663, 2408737, 14952481, 14349472, 3378788, 15753675, 3389346, 8508367, 12017327, 13263417, 11478265, 3967189, 2736500, 7162868, 4474057, 977240, 7239870, 5915940, 445361, 15742259, 21464719, 1437838"
52,"Comparing the quantity and quality of randomised placebo-controlled trials of antibiotics for acute respiratory, urinary, and skin and soft tissue infections: a scoping review",Antibiotics for UTIs,"(""Anti-Bacterial Agents""[Mesh] OR ""Macrolides""[Mesh] OR ""beta-Lactams""[Mesh] OR ""Fluoroquinolones""[Mesh] OR ""Sulfonamides""[Mesh] OR ""Tetracyclines""[Mesh] OR ""Aminoglycosides""[Mesh] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Fluoroquinolones[tiab] OR Sulfonamides[tiab] OR Tetracyclines[tiab] OR Aminoglycosides[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Penicillins[tiab] OR Methicillin[tiab] OR ampicillin[tiab] OR azithromycin[tiab] OR Cephalexin[tiab] OR Maytansine[tiab] OR Mepartricin[tiab] OR Miocamycin[tiab] OR Natamycin[tiab] OR Nystatin[tiab] OR Oleandomycin[tiab] OR Troleandomycin[tiab] OR Oligomycins[tiab] OR Rutamycin[tiab] OR Sirolimus[tiab] OR Everolimus[tiab] OR Tacrolimus[tiab] OR Tylosin[tiab] OR Amphotericin[tiab] OR Antimycin[tiab] OR Brefeldin [tiab] OR Bryostatins [tiab] OR Candicidin[tiab] OR Epothilones[tiab] OR Erythromycin[tiab] OR Azithromycin[tiab] OR Clarithromycin[tiab] OR Ketolides[tiab] OR Roxithromycin[tiab] OR Filipin[tiab] OR Ivermectin[tiab] OR Josamycin[tiab] OR Leucomycins[tiab] OR Kitasamycin[tiab] OR Spiramycin[tiab] OR Carbapenems[tiab] OR Thienamycins[tiab] OR Cephalosporins[tiab] OR Cefamandole[tiab] OR Cefazolin[tiab] OR Cefonicid[tiab] OR Cefsulodin[tiab] OR Cephacetrile[tiab] OR Cephalexin[tiab] OR Cephaloridine[tiab] OR Cephamycins[tiab] OR Clavulanic[tiab] OR Monobactams[tiab] OR Aztreonam[tiab] OR Moxalactam[tiab] OR Amdinocillin[tiab] OR Cyclacillin[tiab] OR Methicillin[tiab] OR Nafcillin[tiab] OR Oxacillin[tiab] OR Penicillanic[tiab] OR Sulbactam[tiab] OR Ticarcillin[tiab] OR Amoxicillin[tiab] OR Ciprofloxacin[tiab] OR Fleroxacin[tiab] OR Enoxacin[tiab] OR Norfloxacin[tiab] OR Ofloxacin[tiab] OR Levofloxacin[tiab] OR Pefloxacin[tiab]) AND (""Placebos""[Mesh] OR Placebos[tiab] OR Placebo[tiab] OR Placeboes[tiab] OR “Sham treatment”[tiab] OR “No treatment”[tiab]) AND (""Urinary Tract Infections""[Mesh] OR “Urinary Tract Infections”[tiab] OR “Urinary Tract Infection”[tiab] OR UTIs[tiab] OR UTI[tiab] OR Cystitis[tiab]) ","1725148, 12236276, 6276973, 17354160, 4552445, 15972728, 7010167"
53,"Comparing the quantity and quality of randomised placebo-controlled trials of antibiotics for acute respiratory, urinary, and skin and soft tissue infections: a scoping review",Antibiotics for ARIs,"(""Anti-Bacterial Agents""[Mesh] OR ""Macrolides""[Mesh] OR ""beta-Lactams""[Mesh] OR ""Fluoroquinolones""[Mesh] OR ""Sulfonamides""[Mesh] OR ""Tetracyclines""[Mesh] OR ""Aminoglycosides""[Mesh] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Fluoroquinolones[tiab] OR Sulfonamides[tiab] OR Tetracyclines[tiab] OR Aminoglycosides[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Penicillins[tiab] OR Methicillin[tiab] OR ampicillin[tiab] OR azithromycin[tiab] OR Cephalexin[tiab] OR Maytansine[tiab] OR Mepartricin[tiab] OR Miocamycin[tiab] OR Natamycin[tiab] OR Nystatin[tiab] OR Oleandomycin[tiab] OR Troleandomycin[tiab] OR Oligomycins[tiab] OR Rutamycin[tiab] OR Sirolimus[tiab] OR Everolimus[tiab] OR Tacrolimus[tiab] OR Tylosin[tiab] OR Amphotericin[tiab] OR Antimycin[tiab] OR Brefeldin [tiab] OR Bryostatins [tiab] OR Candicidin[tiab] OR Epothilones[tiab] OR Erythromycin[tiab] OR Azithromycin[tiab] OR Clarithromycin[tiab] OR Ketolides[tiab] OR Roxithromycin[tiab] OR Filipin[tiab] OR Ivermectin[tiab] OR Josamycin[tiab] OR Leucomycins[tiab] OR Kitasamycin[tiab] OR Spiramycin[tiab] OR Carbapenems[tiab] OR Thienamycins[tiab] OR Cephalosporins[tiab] OR Cefamandole[tiab] OR Cefazolin[tiab] OR Cefonicid[tiab] OR Cefsulodin[tiab] OR Cephacetrile[tiab] OR Cephalexin[tiab] OR Cephaloridine[tiab] OR Cephamycins[tiab] OR Clavulanic[tiab] OR Monobactams[tiab] OR Aztreonam[tiab] OR Moxalactam[tiab] OR Amdinocillin[tiab] OR Cyclacillin[tiab] OR Methicillin[tiab] OR Nafcillin[tiab] OR Oxacillin[tiab] OR Penicillanic[tiab] OR Sulbactam[tiab] OR Ticarcillin[tiab] OR Amoxicillin[tiab] OR Ciprofloxacin[tiab] OR Fleroxacin[tiab] OR Enoxacin[tiab] OR Norfloxacin[tiab] OR Ofloxacin[tiab] OR Levofloxacin[tiab] OR Pefloxacin[tiab]) AND (""Placebos""[Mesh] OR Placebos[tiab] OR Placebo[tiab] OR Placeboes[tiab] OR “Sham treatment”[tiab] OR “No treatment”[tiab] OR “No active treatment”[tiab]) AND (""Respiratory Tract Infections""[Mesh] OR Nasopharyngitis[Mesh] OR Rhinitis[Mesh] OR Sinusitis[Mesh] OR Pharyngitis[Mesh] OR Laryngitis[Mesh] OR bronchitis[Mesh] OR bronchiolitis[Mesh] OR ""bronchiolitis, viral""[Mesh] OR Pleurisy[Mesh] OR Cough[Mesh] OR Sneezing[Mesh] OR Pneumonia[Mesh] OR ""Respiratory Sounds""[Mesh] OR ""Otitis Media""[Mesh] OR Earache[Mesh] OR ""Influenza, Human""[Mesh] OR ""Common Cold""[Mesh] OR “Respiratory infection”[tiab] OR “Respiratory infections”[tiab] OR “Respiratory Tract Infections""[tiab] OR “Respiratory Tract Infection""[tiab] OR “Respiratory inflammation”[tiab] OR “Respiratory tract inflammation”[tiab] OR urti[tiab] OR lrti[tiab] OR ari[tiab] OR nasopharyngitis[tiab] OR rhinopharyngitis[tiab] OR sinusitis[tiab] OR nasosinusitis[tiab] OR rhinosinusitis[tiab] OR rhinitis[tiab] OR rhinorrhoea[tiab] OR rhinorrhea[tiab] OR pharyngitis[tiab] OR ""sore throat""[tiab] OR Tonsillitis[tiab] OR laryngitis[tiab] OR croup[tiab] OR pseudocroup[tiab] OR tracheobronchitis[tiab] OR laryngotracheobronchitis[tiab] OR bronchitis[tiab] OR bronchiolitis[tiab] OR pneumonia[tiab] OR pleuropneumonia[tiab] OR bronchopneumonia[tiab] OR pleurisy[tiab] OR cough[tiab] OR Wheeze[tiab] OR Wheezing[tiab] OR ""otitis media""[tiab] OR aom[tiab] OR ome[tiab] OR earache[tiab] OR influenza[tiab] OR flu[tiab] OR ""common cold""[tiab] OR ""common colds""[tiab]) ","1773154, 18431478, 26575060, 3525736, 12912714, 1912887, 1683673, 13304304, 8945796, 10657332, 8362228, 1493837, 11978253, 3302093, 6611385, 22337680, 11335733, 30419120, 4596108, 7710536, 20422704, 10811043, 13295959, 9721958, 7844685, 21226576, 9219402, 4097904, 4537206, 4565339, 8684101, 8656171, 16278986, 3918190, 15684116, 10737842, 4932022, 8760738, 9569434, 10365577, 28771627, 2612797, 3900239, 15689289, 3057159, 12572527, 6791864, 18559367, 6366769, 17846935, 9051558, 25603000, 3923180, 4148109, 1952710, 3918495, 8457123, 9463979, 26704020, 786428, 1678445, 21226577, 24797294, 329949, 6377256, 9078199, 6117681, 12877377, 8790652, 3520469, 19564277, 6384419, 18056902, 14656841"
8,"Is there a surgeon's effect on patients’ physical health, beyond the intervention, that requires further investigation? A systematic review.",Doctors lifestyle impact on patient care surgeons,"(Physicians[Mesh] OR Doctor[tiab] OR Doctors[tiab] OR Physician[tiab] OR Physicians[tiab] OR Clinician[tiab] OR Clinicians[tiab] OR ""General practitioner""[tiab] OR ""General practitioners""[tiab] OR Cardiologist[tiab] OR Cardiologists[tiab] OR Dermatologist[tiab] OR Dermatologists[tiab] OR Endocrinologist[tiab] OR Endocrinologists[tiab] OR Gastroenterologist[tiab] OR Gastroenterologists[tiab] OR Geriatrician[tiab] OR Geriatricians[tiab] OR Neurologist[tiab] OR Neurologists[tiab] OR Oncologist[tiab] OR Oncologists[tiab] OR Obstetrician[tiab] OR Obstetricians[tiab] OR Pediatrician[tiab] OR Pediatricians[tiab] OR Paediatrician[tiab] OR Paediatricians[tiab] OR Psychiatrist[tiab] OR Psychiatrists[tiab] OR ""Family Physician""[tiab] OR ""Family Physicians""[tiab] OR Surgeon[tiab] OR Surgeons[tiab] OR Urologist[tiab] OR Urologists[tiab] OR Psychiatrist[tiab] OR Psychiatrists[tiab] OR Resident[tiab] OR Residents[tiab] OR Registrar[tiab] OR Registrars[tiab] OR Consultant[tiab] OR Consultants[tiab] OR Specialist[tiab] OR Specialists[tiab]) AND (""Practice Patterns, Physicians”[Mesh] OR ""Clinical Competence""[Mesh] OR Individual[tiab] OR Individuals[tiab]) AND (Variability[tiab] OR Variation[tiab] OR Vary[tiab]) AND (""Outcome and Process Assessment, Health Care""[Mesh] OR ""Quality of Health Care""[Mesh] OR ""Patient Care""[Mesh] OR “Patient care”[tiab] OR “Care quality“[tiab] OR ((Treatment[tiab] OR Medical[tiab] OR Surgical[tiab]) AND (Outcome[tiab] OR Outcomes[tiab]))) AND (Doctor[ti] OR Doctors[ti] OR Physician[ti] OR Physicians[ti] OR Clinician[ti] OR Clinicians[ti] OR ""General practitioner""[ti] OR ""General practitioners""[ti] OR Cardiologist[ti] OR Cardiologists[ti] OR Dermatologist[ti] OR Dermatologists[ti] OR Endocrinologist[ti] OR Endocrinologists[ti] OR Gastroenterologist[ti] OR Gastroenterologists[ti] OR Geriatrician[ti] OR Geriatricians[ti] OR Neurologist[ti] OR Neurologists[ti] OR Oncologist[ti] OR Oncologists[ti] OR Obstetrician[ti] OR Obstetricians[ti] OR Pediatrician[ti] OR Pediatricians[ti] OR Paediatrician[ti] OR Paediatricians[ti] OR Psychiatrist[ti] OR Psychiatrists[ti] OR ""Family Physician""[ti] OR ""Family Physicians""[ti] OR Surgeon[ti] OR Surgeons[ti] OR Urologist[ti] OR Urologists[ti] OR Psychiatrist[ti] OR Psychiatrists[ti] OR Resident[ti] OR Residents[ti] OR Registrar[ti] OR Registrars[ti] OR Consultant[ti] OR Consultants[ti] OR Specialist[ti] OR Specialists[ti] OR Individual[ti] OR Individuals[ti] OR Variability[ti] OR Variation[ti] OR Vary[ti] OR “Patient care”[ti] OR “Care quality“[ti] OR ((Treatment[ti] OR Medical[ti] OR Surgical[ti]) AND (Outcome[ti] OR Outcomes[ti])))","26511481, 28893748, 30174142, 26169083, 16565631, 30562291, 20001170, 31889200, 22716168, 22298678, 26264360, 11948274, 15879851, 20083278, 21095334, 15746131, 12842949, 21846714, 22943610, 17974700, 28614551, 10344676, 30703538, 31342360, 28655057, 29856308, 28528663, 28088321, 22236412, 15189398, 26244543, 24108580, 30562291, 25844969, 30691824, 30396636, 27101502, 24183318, 29940332, 16106480, 14634399, 11807367, 19680280, 30853095, 25048633, 22828825, 30654617, 27050603, 27120446"
103,Increased fluid intake to prevent urinary tract infections: systematic review and meta-analysis,UTI self management for prevention,"(((""Urinary Tract Infections""[Mesh] OR “Urinary Tract Infections”[tiab] OR “Urinary Tract Infection”[tiab] OR UTIs[tiab] OR UTI[tiab] OR Cystitis[tiab]) AND (""Preventive Health Services""[Mesh] OR Prophylaxis[tiab] OR Prevention[tiab] OR Prevent[tiab] OR Preventing[tiab] OR Preventive[tiab] OR ""prevention and control""[sh]) AND (""therapeutic use""[sh] OR Drinking[Mesh] OR ""Drinking Behavior""[Mesh] OR Intervention[tiab] OR Interventions[tiab] OR Therapeutic[tiab] OR “Fluid intake”[tiab] OR “Water Intake”[tiab] OR Hydration[tiab] OR Education[tiab] OR Educational[tiab] OR “behavioral change""[tiab] OR ""behavioral changes""[tiab] OR “behavioural change”[tiab] OR “behavioural changes”[tiab]) AND (Risk[tiab] OR Risks[tiab] OR Rate[tiab] OR Rates[tiab] OR Recurrence[tiab] OR Recurrent[tiab] OR Reducing[tiab] OR Reduction[tiab] OR Reduce[tiab] OR Hinder[tiab])) NOT (""Catheter-Related Infections""[Mesh] OR ""Catheters""[Mesh] OR Catheter[ti] OR Catheters[ti])) AND ((“Urinary Tract Infections”[ti] OR “Urinary Tract Infection”[ti] OR UTIs[ti] OR UTI[ti] OR Cystitis[ti]) AND (Prophylaxis[ti] OR Prevention[ti] OR Prevent[ti] OR Preventing[ti] OR Preventive[ti]) OR (Intervention[ti] OR Interventions[ti] OR Therapeutic[ti] OR “Fluid intake”[ti] OR “Water Intake”[ti] OR Hydration[ti] OR Education[ti] OR Educational[ti] OR “behavioral change""[ti] OR ""behavioral changes""[ti] OR “behavioural change”[ti] OR “behavioural changes”[ti]) OR (Risk[ti] OR Risks[ti] OR Rate[ti] OR Rates[ti] OR Recurrence[ti] OR Recurrent[ti] OR Reducing[ti] OR Reduction[ti] OR Reduce[ti] OR Hinder[ti])) ","30285042, 28608666, 23076891, 29705442, 22305026, 25026919, 11431298, 19921981"
112,"Is there a doctors’ effect on patients’ physical health, beyond the intervention, that requires further investigation? A systematic review.",Doctors lifestyle impact on patient care doctor,"(Physicians[Mesh] OR Doctor[tiab] OR Doctors[tiab] OR Physician[tiab] OR Physicians[tiab] OR Clinician[tiab] OR Clinicians[tiab] OR ""General practitioner""[tiab] OR ""General practitioners""[tiab] OR Cardiologist[tiab] OR Cardiologists[tiab] OR Dermatologist[tiab] OR Dermatologists[tiab] OR Endocrinologist[tiab] OR Endocrinologists[tiab] OR Gastroenterologist[tiab] OR Gastroenterologists[tiab] OR Geriatrician[tiab] OR Geriatricians[tiab] OR Neurologist[tiab] OR Neurologists[tiab] OR Oncologist[tiab] OR Oncologists[tiab] OR Obstetrician[tiab] OR Obstetricians[tiab] OR Pediatrician[tiab] OR Pediatricians[tiab] OR Paediatrician[tiab] OR Paediatricians[tiab] OR Psychiatrist[tiab] OR Psychiatrists[tiab] OR ""Family Physician""[tiab] OR ""Family Physicians""[tiab] OR Surgeon[tiab] OR Surgeons[tiab] OR Urologist[tiab] OR Urologists[tiab] OR Psychiatrist[tiab] OR Psychiatrists[tiab] OR Resident[tiab] OR Residents[tiab] OR Registrar[tiab] OR Registrars[tiab] OR Consultant[tiab] OR Consultants[tiab] OR Specialist[tiab] OR Specialists[tiab]) AND (""Practice Patterns, Physicians”[Mesh] OR ""Clinical Competence""[Mesh] OR Individual[tiab] OR Individuals[tiab]) AND (Variability[tiab] OR Variation[tiab] OR Vary[tiab]) AND (""Outcome and Process Assessment, Health Care""[Mesh] OR ""Quality of Health Care""[Mesh] OR ""Patient Care""[Mesh] OR “Patient care”[tiab] OR “Care quality“[tiab] OR ((Treatment[tiab] OR Medical[tiab] OR Surgical[tiab]) AND (Outcome[tiab] OR Outcomes[tiab]))) AND (""Epidemiologic Studies""[Mesh] OR “case-control studies”[Mesh] OR “Cohort Studies”[Mesh] OR “Case control”[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR Retrospective[tiab] OR “Cross sectional”[tiab] OR “Cross-Sectional Studies”[Mesh] OR Investigated[tiab] OR Analysis[tiab] OR Data[tiab] OR ""statistics and numerical data""[sh] OR ""epidemiology""[sh]) AND (Doctor[ti] OR Doctors[ti] OR Physician[ti] OR Physicians[ti] OR Clinician[ti] OR Clinicians[ti] OR ""General practitioner""[ti] OR ""General practitioners""[ti] OR Cardiologist[ti] OR Cardiologists[ti] OR Dermatologist[ti] OR Dermatologists[ti] OR Endocrinologist[ti] OR Endocrinologists[ti] OR Gastroenterologist[ti] OR Gastroenterologists[ti] OR Geriatrician[ti] OR Geriatricians[ti] OR Neurologist[ti] OR Neurologists[ti] OR Oncologist[ti] OR Oncologists[ti] OR Obstetrician[ti] OR Obstetricians[ti] OR Pediatrician[ti] OR Pediatricians[ti] OR Paediatrician[ti] OR Paediatricians[ti] OR Psychiatrist[ti] OR Psychiatrists[ti] OR ""Family Physician""[ti] OR ""Family Physicians""[ti] OR Surgeon[ti] OR Surgeons[ti] OR Urologist[ti] OR Urologists[ti] OR Psychiatrist[ti] OR Psychiatrists[ti] OR Resident[ti] OR Residents[ti] OR Registrar[ti] OR Registrars[ti] OR Consultant[ti] OR Consultants[ti] OR Specialist[ti] OR Specialists[ti] OR Individual[ti] OR Individuals[ti] OR Variability[ti] OR Variation[ti] OR Vary[ti] OR “Patient care”[ti] OR “Care quality“[ti] OR ((Treatment[ti] OR Medical[ti] OR Surgical[ti]) AND (Outcome[ti] OR Outcomes[ti])))","15833750, 29992198, 25921589, 29283699, 20819110, 20057330, 12479491, 18082004, 18285552, 28454825, 10367820, 26252315, 28893748, 32100020, 24182704, 19279511, 19309714, 22550131, 31108502, 32220936, 28088321, 23698181, 29703654, 27101502, 23129162, 24183318, 26511481, 26130443, 32045308, 26400036"
51,"Comparing the quantity and quality of randomised placebo-controlled trials of antibiotics for acute respiratory, urinary, and skin and soft tissue infections: a scoping review",Antibiotics for skin diseases,"(""Anti-Bacterial Agents""[Mesh] OR ""Macrolides""[Mesh] OR ""beta-Lactams""[Mesh] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Methicillin[tiab] OR ampicillin[tiab] OR azithromycin[tiab] OR Cephalexin[tiab]) AND (""Placebos""[Mesh] OR Placebos[tiab] OR Placebo[tiab] OR Placeboes[tiab] OR “Sham treatment”[tiab]) AND (Erysipelas[Mesh] OR erysipelas[tiab] OR ""Skin Diseases, Infectious""[Mesh] OR Cellulitis[Mesh] OR cellulitis[tiab] OR impetigo[tiab] OR Impetigo[Mesh] OR ""Soft Tissue Infections""[Mesh] OR ""Ignis sacer”[tiab] OR ""holy fire”[tiab] OR ""st anthony's fire""[tiab] OR ""Soft Tissue Infections""[tiab] OR ""Soft Tissue Infection""[tiab] OR ""Skin infections""[tiab] OR ""Skin infection""[tiab] OR ((*Staphylococcus[Mesh] OR staphylococc*[tiab] OR Streptococcus[Mesh] OR streptococc*[tiab]) AND Skin[Mesh])) ","21923567, 6369096, 2112167, 3129741, 28657870, 19409657, 9747366, 26938214, 25340832, 2041927, 18341664, 11809642, 128475, 3880635, 17846141, 29898217, 20346539, 26962903, 23426412"
17,Comparison of immunogenicity and safety of licensed Japanese encephalitis vaccines: A systematic review and network meta-analysis,Japanese encephalitis vaccines immunity,"(""Japan""[Mesh] OR Japanese[tiab] OR Japan[tiab]) AND (""Encephalitis""[Mesh] OR Encephalitis[tiab] OR “Brain Inflammation”[tiab] OR “Brain Inflammations”[tiab] OR “Rasmussen Syndrome”[tiab] OR “Rasmussen's Syndrome”[tiab]) AND (""Vaccines""[Mesh] OR Vaccine[tiab] OR Vaccines[tiab] OR IXIARO[tiab] OR SA14-14-2[tiab]) AND (Inactivated[tiab] OR Immunogenicity[tiab] OR Attenuated[tiab] OR Live[tiab] OR “Cell-derived”[tiab] OR “Cell derived”[tiab]) ","24717964, 21150279, 19857447, 11027812, 25483480, 14575762, 17241714, 12697111, 20864814, 31858116, 25567119, 9359740, 24334689, 20934459, 18061060, 18588481, 2842677, 31755526, 26005163, 19486955, 30833160"
40,Virtual and Augmented Reality Enhancements to Medical and Science Student Physiology and Anatomy Test Performance: A Systematic Review and Meta-Analysis,Virtual reality training for medical students,"(""Education, Professional""[Mesh] OR ((Medical[tiab] OR Biomedical[tiab] OR Health[tiab] OR Anatomy[tiab] OR Anatomical[tiab] OR Neuroanatomy[tiab] OR Pathology[tiab] OR Genetics[tiab] OR pharmacology[tiab] OR bacteriology[tiab] OR Histology[tiab] OR Biochemistry[tiab] OR microbiology[tiab] OR Neurology[tiab] OR “Basic Science”[tiab] OR “Basic Sciences”[tiab] OR Physiology[tiab] OR Physiological[tiab]) AND (Education[tiab] OR Educational[tiab] OR Curriculum[tiab] OR Training[tiab] OR Learning[tiab]))) AND (""Students, Medical""[Mesh] OR Students[tiab] OR Student[tiab]) AND (""Virtual Reality""[Mesh] OR “Virtual Reality”[tiab] OR “Virtual Realities”[tiab] OR “Augmented reality”[tiab] OR “Spatial Computing”[tiab] OR “Mixed Reality”[tiab] OR AR[tiab] OR VR[tiab] OR MR[tiab]) AND (Assessing[tiab] OR Assessments[tiab] OR Assess[tiab] OR Assessed[tiab] OR ((Knowledge[tiab]) AND (Evaluate[tiab] OR Evaluation[tiab] OR acquire[tiab] OR acquirement[tiab] OR Retention[tiab]))) ","23963306, 30648818, 29510979, 26950521, 30295333, 28419750, 28912113, 28719062"
22,Immunogenicity after pre- and post-exposure rabies vaccination: A systematic review and dose-response meta-analysis,Rabies vaccine IM vs ID,"(""rabies vaccines""[Mesh] OR ((vaccination[Mesh]) AND (rabies[Mesh] OR ""rabies virus""[Mesh])) OR ((Rabies[tiab]) AND (vaccine[tiab] OR Vaccines[tiab] OR Vaccination[tiab] OR Vaccinations[tiab] OR Immunise[tiab] OR Immunize[tiab] OR Immunisation[tiab] OR Immunization[tiab]))) AND (""immunization, secondary""[Mesh] OR ""antibodies, viral""[Mesh] OR ""time factors""[Mesh] OR secondary[tiab] OR booster[tiab] OR boost[tiab] OR boosters[tiab] OR boostability[tiab] OR titer[tiab] OR gmt[tiab] OR ((sero[tiab]) AND (conversion[tiab] OR protection[tiab])) OR seroconversion[tiab] OR seroprotection[tiab]) AND (""administration and dosage""[sh] OR Administer[tiab] OR Administered[tiab] OR Administration[tiab] OR Intramuscular[tiab] OR Intradermal[tiab] OR “pre-exposure”[tiab] OR “pre exposure”[tiab]) NOT (animals[Mesh] NOT humans[Mesh]) ","2665351, 7468581, 15541220, 24030586, 3806894, 9004446, 11137239, 7109184, 680382, 20464263, 29631038, 2815976, 7161170, 15379051, 3598225, 24008819, 10575171, 31358408, 26005163, 11535311, 28931127, 17643772, 22178519, 17437473, 2203814, 23583817, 24936103, 10403033, 12962581, 20600481, 23510665, 9849982, 10433577, 20403351, 15603890, 18398307, 18804510, 10452642, 25315021, 31004174, 28317660, 3541428, 23370149, 21809060, 16545510, 29285961, 27554534, 31570311, 14621031, 31743394, 29874228, 7756490, 12471579, 9868840, 24148575, 25692350, 25483635, 20861692, 25692792, 7077095, 2347035, 3620048, 30890382, 30775880, 28406752, 19995217, 28121231, 22699446, 8036824, 3734433, 3812881, 3708902, 28045585, 18431444, 6143187, 6135830"
27,Efficacy of a 3-day pretravel schedule of tafenoquine for malaria chemoprophylaxis: a network meta-analysis,Tafenoquine for both chemoprophylaxis and treatment,"(""Tafenoquine"" [Supplementary Concept] OR Tafenoquine[tiab] OR Arakoda[tiab] OR “WR 238605”[tiab] OR “WR-238605”[tiab] OR Krintafel[tiab])AND(""Malaria""[Mesh] OR Malaria[tiab] OR “Plasmodium infection”[tiab] OR “Plasmodium Infections”[tiab] OR “Remittent Fever”[tiab] OR “Marsh Fever”[tiab] OR Paludism[tiab])AND(""Pre-Exposure Prophylaxis""[Mesh] OR ""Chemoprevention""[Mesh] OR ""prevention and control""[Subheading] OR Prophylaxis[tiab] OR Chemoprophylaxis[tiab] OR Prevention[tiab] OR Prevent[tiab]) ","10885356, 30388194, 26610844, 11584657, 14689348, 15378438, 24700490, 12594633, 19635898, 19995933, 24502679, 11700577"
11,Antibiotics versus delayed or no treatment for asymptomatic bacteriuria in aged care residents: a systematic review and meta-analysis ,Harms of antibiotic prescribing in RACFs,"((""Anti-Infective Agents""[Mesh] OR ""Anti-Bacterial Agents""[Mesh] OR ""Macrolides""[Mesh] OR ""beta-Lactams""[Mesh] OR ""Fluoroquinolones""[Mesh] OR ""Sulfonamides""[Mesh] OR ""Tetracyclines""[Mesh] OR ""Aminoglycosides""[Mesh] OR Antimicrobials[tiab] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Fluoroquinolones[tiab] OR Sulfonamides[tiab] OR Tetracyclines[tiab] OR Aminoglycosides[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Penicillins[tiab] OR Methicillin[tiab] OR ampicillin[tiab] OR azithromycin[tiab] OR Cephalexin[tiab] OR Maytansine[tiab] OR Mepartricin[tiab] OR Miocamycin[tiab] OR Natamycin[tiab] OR Nystatin[tiab] OR Oleandomycin[tiab] OR Troleandomycin[tiab] OR Oligomycins[tiab] OR Rutamycin[tiab] OR Sirolimus[tiab] OR Everolimus[tiab] OR Tacrolimus[tiab] OR Tylosin[tiab] OR Amphotericin[tiab] OR Antimycin[tiab] OR Brefeldin [tiab] OR Bryostatins [tiab] OR Candicidin[tiab] OR Epothilones[tiab] OR Erythromycin[tiab] OR Azithromycin[tiab] OR Clarithromycin[tiab] OR Ketolides[tiab] OR Roxithromycin[tiab] OR Filipin[tiab] OR Ivermectin[tiab] OR Josamycin[tiab] OR Leucomycins[tiab] OR Kitasamycin[tiab] OR Spiramycin[tiab] OR Carbapenems[tiab] OR Thienamycins[tiab] OR Cephalosporins[tiab] OR Cefamandole[tiab] OR Cefazolin[tiab] OR Cefonicid[tiab] OR Cefsulodin[tiab] OR Cephacetrile[tiab] OR Cephalexin[tiab] OR Cephaloridine[tiab] OR Cephamycins[tiab] OR Clavulanic[tiab] OR Monobactams[tiab] OR Aztreonam[tiab] OR Moxalactam[tiab] OR Amdinocillin[tiab] OR Cyclacillin[tiab] OR Methicillin[tiab] OR Nafcillin[tiab] OR Oxacillin[tiab] OR Penicillanic[tiab] OR Sulbactam[tiab] OR Ticarcillin[tiab] OR Amoxicillin[tiab] OR Ciprofloxacin[tiab] OR Fleroxacin[tiab] OR Enoxacin[tiab] OR Norfloxacin[tiab] OR Ofloxacin[tiab] OR Levofloxacin[tiab] OR Pefloxacin[tiab] OR Quinolone[tiab]) AND (""Homes for the Aged""[Mesh] OR ""Old Age Homes""[tiab] OR ""Old Age Home""[tiab] OR “Nursing Homes”[Mesh] OR “Nursing Home”[tiab] OR “Geriatric center”[tiab] OR “Geriatric centers”[tiab] OR “Retirement communities”[tiab] OR “Retirement community”[tiab] OR “Nonhospitalized”[tiab] OR “Non Hospitalized”[tiab] OR “Nonhospitalised”[tiab] OR “Non Hospitalised”[tiab] OR “Aged care”[tiab] OR “Retirement home”[tiab] OR “Retirement homes”[tiab]) AND (“Aged”[Mesh] OR “Elderly”[tiab] OR Old[tiab] OR Older[tiab]) AND (""Adverse effects""[sh] OR “Infections”[Mesh] OR “Adverse effect”[tiab] OR “Adverse effects”[tiab] OR “Adversely affect”[tiab] OR “Adverse event”[tiab] OR “Adverse events”[tiab] OR “Poisoning”[tiab] OR “Toxicity”[tiab] OR “Discomfort”[tiab] OR “Pain”[tiab] OR “Physiological impacts”[tiab] OR “Physiological impact”[tiab] OR Mortality[tiab] OR Survival[tiab] OR “Infection”[tiab] OR “Infections”[tiab] OR “Symptomatic”[tiab]) AND (“Withholding Treatment”[Mesh] OR Placebo[Mesh] OR Placebo[tiab] OR Untreated[tiab] OR “No therapy”[tiab] OR “No Treatments”[tiab] OR “No Treatment”[tiab] OR ((Withholding[tiab] OR Withdrawing OR Stopping OR Ceasing[tiab] OR Discontinuation[tiab]) AND (Treatments[tiab] OR Treatment[tiab] OR Therapy[tiab]))) AND (“randomized controlled trial”[pt] OR “controlled clinical trial”[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR ""Epidemiologic Studies""[Mesh] OR “case-control studies”[Mesh] OR “Cohort Studies”[Mesh] OR “case control”[tiab] OR Cohort[tiab] OR “Follow up”[tiab] OR Observational[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR Retrospective[tiab] OR “cross sectional”[tiab] OR “Cross-Sectional Studies”[Mesh] OR Evaluated[tiab] OR Impact[tiab] OR Analysis[tiab] OR Statistics[tiab] OR Data[tiab] OR ""statistics and numerical data""[sh] OR ""epidemiology""[sh] OR Etiology[sh] OR Effect[tiab] OR Effects[tiab] OR Affect[tiab])) OR ((Antibiotics[ti] OR Antibiotic[ti] OR Penicillin[ti] OR Penicillins[ti] OR azithromycin[ti] OR Azithromycin[ti] OR Cephalexin[ti] OR Oxacillin[ti] OR Ciprofloxacin[ti] OR Ofloxacin[ti] OR Quinolone[ti]) AND (Elderly[ti] OR Old[ti] OR Older[ti] OR Aged[ti] OR Age[ti]) AND (Impairment[ti] OR Mortality[ti] OR Harms[ti] OR Harm[ti] OR Adverse[ti] OR Survival[ti])) ","17434828, 8549366, 6633618, 3300325, 8600199, 7818631, 3806896"
47,Effectiveness and sustainability of deprescribing for hospitalized older patients near end of life: a systematic review,Deprescribing near end of life,"( Deprescriptions[Mesh] OR Deprescription[tiab] OR Deprescribing[tiab] OR Deprescribe[tiab] OR Deprescribed[tiab] OR ((Inappropriate[tiab] OR Ceased[tiab] OR Cease[tiab] OR Substituted[tiab] OR Reduce[tiab] OR Reduced[tiab] OR Reduction[tiab] OR Stopped[tiab] OR Stop[tiab] OR Discontinue[tiab] OR Discontinued[tiab] OR Discontinuing[tiab] OR Withdraw[tiab] OR Withdrawing[tiab] OR Withdrawl[tiab] OR Withdrawal[tiab]) AND (Medication[tiab] OR Medications[tiab] OR Polypharmacy[Mesh] OR Polypharmacy[tiab] OR Prescribing[tiab])) ) AND (Aged[Mesh] OR Elderly[tiab] OR Older[tiab] OR Old[tiab]) AND (""Terminal Care""[Mesh] OR ""Nursing Homes""[Mesh] OR ""Frail Elderly""[Mesh] OR “Aged care”[tiab] OR Life[tiab] OR “Last year”[tiab] OR Hospitalization[tiab] OR Hospitalisation[tiab] OR Hospitalized[tiab] OR Hospitalised[tiab] OR Chronic[tiab]) AND (Effective[tiab] OR Effectiveness[tiab] OR Efficacy[tiab] OR Reduction[tiab] OR Implemented[tiab] OR Benefit[tiab] OR Adverse[tiab]) AND ((“randomized controlled trial”[pt] OR “controlled clinical trial”[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR “Cohort Studies”[Mesh] OR Cohort[tiab] OR “Follow up”[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR Investigated[tiab] OR Analysis[tiab] OR Statistics[tiab] OR Data[tiab] OR ""statistics and numerical data""[sh] OR ""epidemiology""[sh]) OR (((Search[tiab] OR Searched[tiab]) AND (PubMed[tiab] OR MEDLINE[tiab])) OR (systematic[tiab] AND review[tiab]) OR ((systematically[tiab] OR reviewed[tiab]) AND literature[tiab]) OR meta analysis[Publication Type]) OR (""Cochrane Database Syst Rev""[jour])) AND (""Hospitals""[Mesh] OR ""Hospital Medicine""[Mesh] OR ""Intensive Care Units""[Mesh] OR Hospitalization[tiab] OR Hospitalisation[tiab] OR Hospitalized[tiab] OR Hospitalised[tiab] OR Hospital[tiab] OR “Intensive care”[tiab]) ","31868920, 24566877, 15903284, 19433702, 2229860, 29246247, 30006810"
102,Effect of Immediate Administration of Antibiotics in Patients With Sepsis in Tertiary Care: A Systematic Review and Meta-analysis,Timing of antibiotics for sepsis,"(""Anti-Bacterial Agents""[Mesh] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab]) AND (""Sepsis""[Mesh] OR Sepsis[tiab] OR “Septic shock”[tiab] OR “Systemic inflammatory response syndrome”[tiab] OR Septicemia[tiab] OR Septicemias[tiab]) AND (""Mortality""[Mesh] OR “Survival Rate""[Mesh] OR ""Survival Analysis""[Mesh] OR Mortality[tiab] OR Death[tiab] OR Deaths[tiab] OR Survival[tiab]) AND (""Emergency Service, Hospital""[Mesh] OR “Emergency service”[tiab] OR “Emergency services”[tiab] OR “Emergency department”[tiab] OR “Emergency departments”[tiab] OR “Emergency Units”[tiab] OR “Emergency Unit”[tiab] OR ED[tiab] OR ""Intensive Care Units""[Mesh] OR ""Intensive Care Units""[tiab] OR ""Intensive Care Unit""[tiab] OR ICU[tiab] OR ICUs[tiab]) AND (""Time-to-Treatment""[Mesh] OR Timing[tiab] OR “Time to”[tiab] OR Hour[tiab] OR Hours[tiab]) AND (Administration[tiab] OR Appropriate[tiab] OR Appropriateness[tiab] OR Compliance[tiab]) ","21572327, 24717459, 21549546, 26573784, 19696442, 25651372, 24970941, 25925412, 25847048, 23945889, 20048677"
16,The impact of antibiotics on clinical response over time in uncomplicated cellulitis: a systematic review and meta-analysis,Intravenous versus Oral antibiotics for cellulitis,"(""Anti-Bacterial Agents""[Mesh] OR ""Macrolides""[Mesh] OR ""beta-Lactams""[Mesh] OR ""Fluoroquinolones""[Mesh] OR ""Sulfonamides""[Mesh] OR ""Tetracyclines""[Mesh] OR ""Aminoglycosides""[Mesh] OR Antimicrobials[tiab] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Fluoroquinolones[tiab] OR Sulfonamides[tiab] OR Tetracyclines[tiab] OR Aminoglycosides[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Penicillins[tiab] OR Methicillin[tiab] OR ampicillin[tiab] OR azithromycin[tiab] OR Cephalexin[tiab] OR Maytansine[tiab] OR Mepartricin[tiab] OR Miocamycin[tiab] OR Natamycin[tiab] OR Nystatin[tiab] OR Oleandomycin[tiab] OR Troleandomycin[tiab] OR Oligomycins[tiab] OR Rutamycin[tiab] OR Sirolimus[tiab] OR Everolimus[tiab] OR Tacrolimus[tiab] OR Tylosin[tiab] OR Amphotericin[tiab] OR Antimycin[tiab] OR Brefeldin [tiab] OR Bryostatins [tiab] OR Candicidin[tiab] OR Epothilones[tiab] OR Erythromycin[tiab] OR Azithromycin[tiab] OR Clarithromycin[tiab] OR Ketolides[tiab] OR Roxithromycin[tiab] OR Filipin[tiab] OR Ivermectin[tiab] OR Josamycin[tiab] OR Leucomycins[tiab] OR Kitasamycin[tiab] OR Spiramycin[tiab] OR Carbapenems[tiab] OR Thienamycins[tiab] OR Cephalosporins[tiab] OR Cefamandole[tiab] OR Cefazolin[tiab] OR Cefonicid[tiab] OR Cefsulodin[tiab] OR Cephacetrile[tiab] OR Cephalexin[tiab] OR Cephaloridine[tiab] OR Cephamycins[tiab] OR Clavulanic[tiab] OR Monobactams[tiab] OR Aztreonam[tiab] OR Moxalactam[tiab] OR Amdinocillin[tiab] OR Cyclacillin[tiab] OR Methicillin[tiab] OR Nafcillin[tiab] OR Oxacillin[tiab] OR Penicillanic[tiab] OR Sulbactam[tiab] OR Ticarcillin[tiab] OR Amoxicillin[tiab] OR Ciprofloxacin[tiab] OR Fleroxacin[tiab] OR Enoxacin[tiab] OR Norfloxacin[tiab] OR Ofloxacin[tiab] OR Levofloxacin[tiab] OR Pefloxacin[tiab]) AND (Erysipelas[Mesh] OR Erysipelas[tiab] OR ""Skin Diseases, Infectious""[Mesh] OR Cellulitis[Mesh] OR Cellulitis[tiab] OR Impetigo[tiab] OR Impetigo[Mesh] OR ""Soft Tissue Infections""[Mesh] OR ""Holy fire”[tiab] OR ""st anthony's fire""[tiab] OR ""Soft Tissue Infections""[tiab] OR ""Soft Tissue Infection""[tiab] OR ""Skin infections""[tiab] OR ""Skin infection""[tiab] OR ((Staphylococcus[Mesh] OR staphylococcus[tiab] OR Streptococcus[Mesh] OR streptococcus[tiab]) AND (Skin[Mesh] OR Skin[tiab]))) AND (""Administration, Oral""[Mesh] OR Oral[tiab] OR Orally[tiab]) AND (""Infusions, Parenteral""[Mesh] OR ""Injections, Intravenous""[Mesh] OR Intravenous[tiab] OR Intravenously[tiab] OR IV[tiab] OR parenteral[tiab] OR parenterally[tiab])","12182257, 15302637, 29281036, 26679243, 1512105, 28480266, 31474458, 23457080, 29029278, 9589816, 11451697, 32747361, 31660410, 30853250, 28274772, 15843702, 1390144, 31618678, 15604157, 9360253, 28314743, 24897082, 30988146, 8818853, 24909499, 31367742, 19222623, 23403680, 8396081, 25336165, 12386036, 28535235"
60,Effectiveness of Different Topical Treatments in the Healing of Pressure Injuries: A Network Meta-analysis,Dressing for pressure ulcers: a network meta-analysis,"(Bandages[Mesh] OR Alginates[Mesh] OR Hydrogels[Mesh] OR Silver[Mesh] OR ""Silver Sulfadiazine""[Mesh] OR Honey[Mesh] OR ""Collagenases""[Mesh] OR Bandage[tiab] OR Bandages[tiab] OR Dressing[tiab] OR Dressings[tiab] OR Pad[tiab] OR Pads[tiab] OR Gauze[tiab] OR Tulle[tiab] OR Film[tiab] OR Films[tiab] OR Alginate[tiab] OR Alginates[tiab] OR Hydrogel[tiab] OR Hydrogels[tiab] OR Silver OR Bead[tiab] OR Foam[tiab] OR Foams[tiab] OR non-adherent[tiab] OR ""non adherent""[tiab] OR hydrocolloid[tiab] OR Hydrocolloids[tiab] OR Honey[tiab] OR Honeys[tiab] OR matrix[tiab] OR Collagenases[tiab] OR Collagenase[tiab]) AND (""Pressure Ulcer""[Mesh] OR “Pressure ulcer”[tiab] OR “Pressure ulcers”[tiab] OR Bedsore[tiab] OR Bedsores[tiab] OR “Pressure Sore”[tiab] OR “Pressure Sores”[tiab] OR “Bed Sores”[tiab] OR “Bed Sore”[tiab] OR “Decubitus Ulcer”[tiab] OR “Decubitus Ulcers”[tiab]) AND (""Wound Healing""[Mesh] OR ""Debridement""[Mesh] OR Healing[tiab] OR Healings[tiab] OR “Wound therapy”[tiab] OR Debridement[tiab] OR Debridements[tiab] OR “Wound treatment”[tiab] OR Treating[tiab])","2694713, 22839453, 9455271, 27922396, 27922299, 12028208, 2193631, 18385577, 8297488, 2202317, 12142596, 3555355, 12558709, 11899912, 15601464, 8826783, 8286026, 11235499, 14568851, 10207960, 6688261, 11772156, 8304833, 16060184, 3519718, 11248182, 19246785, 23103485, 11933306, 24848975, 10417749, 20455960, 3533007, 10655861, 18284391, 11933727, 10326343, 15871870, 1580775"
15,Australian state influenza notifications and school holiday closures in 2019,Influenza rates with school closures,"(""Influenza, Human""[Mesh] OR Influenza[tiab] OR “Respiratory viruses”[tiab]) AND (Schools[Mesh] OR School[tiab] OR Schools[tiab] OR ((Children[tiab]) AND (Community)) OR ((""Young Adult""[Mesh] OR ""Adolescent""[Mesh] OR Child[Mesh] OR Infant[Mesh]) AND (""Population Surveillance""[Mesh] OR Pandemics[Mesh] OR Pandemic[tiab] OR Pandemics[tiab]))) AND (""Absenteeism""[Mesh] OR Closure[tiab] OR Closures[tiab] OR Closed[tiab] OR Vacation[tiab] OR Holiday[tiab] OR Holidays[tiab] OR Outbreak[tiab] OR Outbreaks[tiab] OR Dismissed[tiab] OR Epidemiological[tiab] OR Surveillance[tiab]) AND (Incidence[Mesh] OR Morbidity[Mesh] OR ""Population Surveillance""[Mesh] OR ""Disease Notification""[Mesh] OR ""Disease Outbreaks""[Mesh] OR Incidence[tiab] OR Morbidity[tiab] OR Mortality[tiab] OR Case[tiab] OR Cases[tiab]) ","28031259, 23447463, 29321005, 29396256, 22335933, 33976871, 24230961, 24830407, 19679750, 19679750, 24230961"
39,The effectiveness of parasympathomimetics for treating underactive bladder: A systematic review and meta‐analysis,Underactive bladder treatments,"(""Urinary Bladder, Underactive""[Mesh] OR ""Urinary Retention""[Mesh] OR ""Urodynamics""[Mesh] OR “Residual urine”[tiab] OR “Urinary retention”[tiab] OR “Urodynamic study”[tiab] OR “Urodynamic parameters”[tiab] OR ((Underactive[tiab] OR Underactivity[tiab] OR Hypotonic[tiab] OR Acontractile[tiab] OR hypocontractility[tiab] OR Failure[tiab] OR Areflexia[tiab] OR Atonic[tiab] Impaired[tiab] OR Dysfunction[tiab]) AND (Bladder[tiab] OR Bladders[tiab] OR Detrusor[tiab] OR Detrusors[tiab]))) AND (""Parasympathomimetics""[Mesh] OR ""Parasympathomimetics""[Pharmacological Action] OR  ""Receptors, Muscarinic""[Mesh] OR ""Bethanechol""[Mesh] OR ""Bethanechol Compounds""[Mesh] OR ""Carbachol""[Mesh] OR ""Diazepam""[Mesh] OR ""Cisapride""[Mesh] OR ""Phenoxybenzamine""[Mesh] OR ""Dinoprost""[Mesh] OR ""Neostigmine""[Mesh] OR Parasympathomimetics[tiab] OR Parasympathomimetic[tiab] OR Muscarinic[tiab] OR Bethanechol[tiab] OR Bethanecol[tiab] OR Duvoid[tiab] OR Myotonine[tiab] OR Myocholine[tiab] OR PMS-Bethanechol[tiab] OR Urocarb[tiab] OR Myotonachol[tiab] OR Urecholine[tiab] OR Carbachol[tiab] OR Diazepam[tiab] OR Alfusozine[tiab] OR ""Cisapride""[tiab] OR “Distigmine bromide”[tiab] OR Phenoxybenzamine[tiab] OR Prostaglandin[tiab] OR ""Neostigmine""[tiab] OR (Myo[tiab] AND Hermes[tiab])) ","6117662, 3803106, 9291399, 13458255, 9449585, 15959612, 21546875, 1682174, 30254450"
46,Dementia caregiving in the Middle East and North Africa: A scoping review,Dementia care in the middle east,"(((""Dementia""[MeSH] OR Dementia[tiab] OR Dementias[tiab] OR Demented[tiab] OR ""Neurocognitive Disorders""[tiab] OR ""Neurocognitive Disorder""[tiab] OR ""Memory disorders""[tiab] OR ""Memory disorder""[tiab] OR ""Cognitive decline""[tiab] OR ""cognitive disorders""[tiab] OR Alzheimer[tiab] OR Alzheimers[tiab] OR alzheimer’s[tiab])) OR (""Caregivers""[Mesh] OR Caregivers[tiab] OR Caregiver[tiab] OR Carer[tiab] OR Carers[tiab])) OR ((Cultural[tiab] OR Culturally[tiab]) AND Care[tiab]) AND (""africa, northern""[Mesh] OR ""northern africa""[tiab] OR “North africa”[tiab] OR ""algeria""[Mesh] OR ""algeria""[tiab] OR ""egypt""[Mesh] OR ""egypt""[tiab] OR ""libya""[Mesh] OR ""libya""[tiab] OR ""morocco""[Mesh] OR ""morocco""[tiab] OR ""tunisia""[Mesh] OR ""tunisia""[tiab] OR ""sudan""[Mesh] OR ""sudan""[tiab] OR ""middle east""[Mesh] OR ""middle east""[tiab] OR ""bahrain""[Mesh] OR ""bahrain""[tiab] OR ""iraq""[Mesh] OR ""iraq""[tiab] OR ""jordan""[Mesh] OR ""jordan""[tiab] OR ""kuwait""[Mesh] OR ""kuwait""[tiab] OR ""lebanon""[Mesh] OR ""lebanon""[tiab] OR ""oman""[Mesh] OR ""oman""[tiab] OR ""qatar""[Mesh] OR ""qatar""[tiab] OR ""saudi arabia""[Mesh] OR ""saudi arabia""[tiab] OR ""syria""[Mesh] OR ""syria""[tiab] OR “united arab emirates""[Mesh] OR ""united arab emirates""[tiab] OR ""yemen""[Mesh] OR ""yemen""[tiab] OR ""somalia""[Mesh] OR ""somalia""[tiab] OR ""mauritania""[Mesh] OR ""mauritania""[tiab] OR ""djibouti""[Mesh] OR ""djibouti""[tiab] OR ""arabs""[Mesh] OR ""arabs""[tiab] OR Arab[tiab] OR ""comoros""[Mesh] OR ""comoros""[tiab] OR lebanese[tiab] OR libanaise[tiab] OR ""aden""[tiab] OR ""sanaa""[tiab] OR UAE[tiab] OR ""abu dhabi""[tiab] OR dubai[tiab] OR ""muscat""[tiab] OR palestina[tiab] OR palestinae[tiab] OR palestine[tiab] OR palestinians[tiab] OR gaza[tiab] OR ""west bank""[tiab] OR KSA[tiab] OR tunis[tiab] OR MENA[tiab] OR EMRO[tiab] OR ""arabia""[Mesh] OR ""arabia""[tiab] OR somali[tiab] OR ""mauritania""[Mesh] OR ""mauritania""[tiab] OR levant[tiab] OR Gulf[tiab] OR “Arabian Gulf”[tiab] OR ""persian gulf""[tiab]) AND (""Aging""[Mesh] OR ""Aged""[Mesh] OR ""Aging""[tiab] OR Aged[tiab] OR ""Senility""[tiab] OR ""old age""[tiab] OR ""elderly""[tiab] OR Older[tiab]) ","29082106, 28932158, 29093925, 28890585, 27776566, 28579315, 29336168, 25043103, 22384291, 20803723, 11340323, 19161123, 21748130, 16083486, 18618233"
42,"Comparing the quantity and quality of randomised placebo-controlled trials of antibiotics for acute respiratory, urinary, and skin and soft tissue infections: a scoping review",Assessing the quality of quality scoring,"( (""Checklist""[Mesh] OR ""Forms and Records Control""[Mesh] OR Checklist[tiab] OR Checklists[tiab] OR Tool[tiab] OR Tools[tiab] OR Scale[tiab] OR Scales[tiab] OR Score[tiab] OR Scores[tiab] OR Scored[tiab]) AND (""Research Design/methods""[Mesh] OR ""Research Design/standards""[Mesh] OR Valid[tiab] OR Validity[tiab] OR Quality[tiab] OR “Critical appraisal”[tiab] OR “Critical review”[tiab] OR Bias[tiab] OR Biased[tiab]) AND (Assess[tiab] OR Assessed[tiab] OR Assessing[tiab] OR Assessment[tiab] OR Measure[tiab] OR Measures[tiab] OR Measured[tiab] OR Evaluate[tiab] OR Evaluated[tiab] OR Evaluating[tiab]) AND (""Meta-Analysis as Topic""[Mesh] OR ""Review Literature as Topic""[Mesh] OR ""Clinical Trials as Topic""[Mesh] OR Study[tiab] OR Studies[tiab] OR Article[tiab] OR Articles[tiab] OR Meta-Analysis[tiab] OR “Meta Analysis”[tiab] OR Metaanalysis[tiab] OR Meta-analyses[tiab] OR “Meta analyses”[tiab] OR Metaanalyses[tiab]) AND (""Methods""[Mesh] OR Method[tiab] OR Methodological[tiab] OR Methodology[tiab] OR Methodologic[tiab]) AND (""Reproducibility of Results""[Mesh] OR ""Quality Control""[Mesh] OR Reproducibility[tiab] OR Evidence[tiab] OR Reliability[tiab] OR Reliable[tiab] OR Index[tiab] OR Proxy[tiab]) ) AND ( (Scale[ti] OR Scales[ti] OR Checklist[ti] OR Checklists[ti] OR Tool[ti] OR Tools[ti] OR Instrument[ti] OR Instruments[ti] OR Technique[ti] OR Techniques[ti] OR Score[ti] OR Scored[ti] OR Quality[ti] OR Assess[ti] OR Assessed[ti] OR Assessing[ti] OR Assessment[ti] OR Evaluate[ti] OR Evaluated[ti] OR Evaluating[ti])) ","29490062, 29314757, 28554944, 27919275, 25335150, 23887867, 22258953, 22008217, 22000072, 19195714, 15708101, 15014055"
64,Metformin in pregnancy to avert gestational diabetes in women at high risk: Meta-analysis of randomized controlled trials,Metformin for diabetes mellitus,"((""Diabetes, Gestational""[Mesh] OR “Gestational diabetes”[tiab] OR “Pregnancy-Induced Diabetes”[tiab] OR “Pregnancy Induced Diabetes”[tiab]) OR ((Overweight[tiab] OR Obese[tiab]) AND (Pregnant[tiab] OR Pregnancy[tiab])) ) AND (""Metformin""[Mesh] OR Metformin[tiab] OR Dimethylbiguanidine[tiab] OR Dimethylguanylguanidine[tiab] OR Glucophage[tiab]) AND (""Pregnancy Complications""[Mesh] OR Prevention[tiab] OR Preventing[tiab] OR Complication[tiab] OR Complications[tiab] OR Risk[tiab] OR “androgen excess”[tiab] OR hyperandrogenism[tiab] OR “polycystic ovary syndrome”[tiab] OR “polycystic ovarian syndrome”[tiab] OR “polycystic ovarian disease”[tiab] OR “polycystic ovaries”[tiab] OR PCOS[tiab] OR hirsutism[tiab] OR acne[tiab] OR alopecia[tiab] OR “menstrual dysfunction”[tiab] OR anovulation[tiab] OR infertility[tiab] OR subfertility[tiab] OR “ovulation induction”[tiab]) ","30792154, 30528218, 18651320, 29702716, 29422358, 19708174, 20926533, 25243003, 26840133, 26165398, 29094444"
6,Metformin is comparable to insulin for pharmacotherapy in gestational diabetes mellitus: A network meta-analysis evaluating 6046 women,Drug management of GDM,"((""Diabetes, Gestational""[Mesh] OR “Gestational diabetes”[tiab] OR “Pregnancy-Induced Diabetes”[tiab] OR “Pregnancy Induced Diabetes”[tiab]) AND (""Glyburide""[Mesh] OR ""Acarbose""[Mesh] OR ""Metformin""[Mesh] OR ""Biguanides""[Mesh] OR ""Sulfonylurea Compounds""[Mesh] OR ""Thiazolidinediones""[Mesh] OR ""Dipeptidyl-Peptidase IV Inhibitors""[Mesh] OR ""Glycoside Hydrolase Inhibitors""[Mesh] OR ""Sodium-Glucose Transporter 2 Inhibitors""[Mesh] OR ""Insulin""[Mesh] OR ""Glucagon-Like Peptide 1""[Mesh] OR ""Exenatide""[Mesh] OR ""Glipizide""[Mesh] OR ""Insulin Lispro""[Mesh] OR ""Isophane Insulin, Human""[Mesh] OR ""Insulin, Isophane""[Mesh] OR ""Insulin Glargine""[Mesh] OR ""Insulins""[Mesh] OR ""Xultophy"" [Supplementary Concept] OR ""Liraglutide""[Mesh] OR ""Linagliptin""[Mesh] OR ""repaglinide"" [Supplementary Concept] OR ""Sitagliptin Phosphate""[Mesh] OR (""Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination""[Mesh] OR ""empagliflozin"" [Supplementary Concept] OR ""dulaglutide"" [Supplementary Concept] OR Glyburide[tiab] OR Glybenclamide[tiab] OR Glibenclamide[tiab] OR Diabeta[tiab] OR “Euglucon 5”[tiab] OR Neogluconin[tiab] OR HB-419[tiab] OR “HB 419”[tiab] OR HB419[tiab] OR HB-420[tiab] OR “HB 420”[tiab] OR HB420[tiab] OR Maninil[tiab] OR Micronase[tiab] OR Daonil[tiab] OR “Euglucon N”[tiab] OR ""Acarbose""[tiab] OR Glumida[tiab] OR Glucobay[tiab] OR Glucor[tiab] OR “Bay g 5421”[tiab] OR Prandase[tiab] OR Precose[tiab] OR ""Metformin""[tiab] OR Dimethylbiguanidine[tiab] OR Dimethylguanylguanidine[tiab] OR Glucophage[tiab] OR biguanides[tiab] OR sulfonylureas[tiab] OR meglitinides[tiab] OR thiazolidinediones[tiab] OR “dipeptidyl peptidase IV inhibitors”[tiab] OR “DPP-IV inhibitors”[tiab] OR “α-glucosidase inhibitors”[tiab] OR “SGLT2 inhibitors”[tiab] OR gliflozins[tiab] OR Insulin[tiab] OR “Glucagon like peptide–1”[tiab] OR “GLP-1 agonists”[tiab] OR Amylinomimetics[tiab] OR Exenatide[tiab] OR Glicalzide[tiab] OR Glimepride[tiab] OR Glipizide[tiab] OR Mixtard[tiab] OR Actrapid[tiab] OR Humalog[tiab] OR Insulatard[tiab] OR Isophane[tiab] OR Glargine[tiab] OR “Levemir Detemir”[tiab] OR “Degludec pen”[tiab] OR “Novomix pen”[tiab] OR “Novoraid vial”[tiab] OR “Saxenda liraglutide”[tiab] OR Linagliptin[tiab] OR Dapagliflozin[tiab] OR Piogitazine[tiab] OR Repaglinide[tiab] OR “Galvus met”[tiab] OR Vidagliptin[tiab] OR Sitagliptin[tiab] OR Janumet[tiab] OR Empagliflozin[tiab] OR Dulaglutide[tiab]) AND (“Therapeutic use”[sh] OR Therapeutic[tiab] OR Therapy[tiab] OR Therapies[tiab]) AND (Effect[tiab] OR Effects[tiab] OR Impact[tiab] OR Modify[tiab] OR Decrease[tiab] OR Decreases[tiab] OR Declined[tiab] OR Declines[tiab] OR Reduce[tiab] OR Reducing[tiab] OR Reduces[tiab] OR Reduction[tiab] OR Differences[tiab] OR Difference[tiab] OR Different[tiab] OR Comparing[tiab] OR Versus[tiab]) AND (""Female""[Mesh] OR Female[tiab] OR Females[tiab] OR Women[tiab] OR Woman[tiab])","23524173, 28077460, 20027034, 16318615, 25725178, 17669723, 17684614, 23718748, 29715355, 17113179, 27413519, 19375570, 31427334, 11036118, 25467617, 26992090, 30191995, 24217938, 21083860, 18161398, 23068960, 18463376, 23020608, 27226182, 24304990, 23626890, 25538782, 27597988, 25688819, 22505499"
7,Physical activity in pregnancy prevents gestational diabetes: A meta-analysis,The effect of lifestyle (exercise or diet) on pregnancy outcomes,"(""Life Style""[Mesh] OR ""Diet""[Mesh] OR ""Exercise""[Mesh] OR ""Patient Education as Topic""[Mesh] OR ""Life Style""[tiab] OR Lifestyle[tiab] OR Exercise[tiab] OR Counseling[tiab] OR Dietary[tiab] OR Dieting[tiab] OR Educational[tiab] OR “Patient education”[tiab] OR “Eating habits”[tiab] OR “Eating patterns”[tiab] OR “Weight measurement”[tiab]) AND (""Pregnancy Outcome""[Mesh] OR ""Pregnancy Complications""[Mesh] OR “Birth weight”[Mesh] OR ""Pregnancy Outcome""[tiab] OR ""Pregnancy Outcomes""[tiab] OR ""Pregnancy Complications""[tiab] OR ""Pregnancy Complication""[tiab] OR ((Pregnancy[Mesh] OR Pregnancy[tiab] OR Gestational[tiab]) AND (“Weight Gain”[Mesh] OR “Weight gain”[tiab] OR “Glucose metabolism”[tiab]))) AND (""Treatment Outcome""[Mesh] OR Effect[tiab] OR Effects[tiab] OR Impact[tiab] OR Modify[tiab] OR Decrease[tiab] OR Decreases[tiab] OR Declined[tiab] OR Declines[tiab] OR Reduce[tiab] OR Reducing[tiab] OR Reduces[tiab] OR Reduction[tiab] OR Change[tiab] OR Changes[tiab] OR Differences[tiab] OR Difference[tiab] OR Different[tiab]) AND (""Risk Reduction Behavior""[Mesh] OR ""Primary Prevention""[Mesh] OR ""prevention and control""[sh] OR Prevent[tiab] OR Prevents[tiab] OR Preventing[tiab] OR Unfavorable[tiab] OR Adverse[tiab] OR Retention[tiab] OR Activity[tiab] OR Capacity[tiab] OR Negative[tiab] OR Restrict[tiab] OR Restricted[tiab] OR Adherence[tiab] OR Assess[tiab] OR Assessed[tiab]) AND (""Life Style""[ti] OR Lifestyle[ti] OR Exercise[ti] OR Counseling[ti] OR Diet[ti] OR Dietary[ti] OR Dieting[ti] OR Educational[ti] OR “Patient education”[ti] OR “Eating habits”[ti] OR “Eating patterns”[ti] OR “Weight measurement”[ti] OR Pregnant[ti] OR ""Pregnancy Outcome""[ti] OR ""Pregnancy Outcomes""[ti] OR ""Pregnancy Complications""[ti] OR ""Pregnancy Complication""[ti] OR Pregnancy[ti] OR Gestational[ti] OR “Weight gain”[ti] OR “Glucose metabolism”[ti]) ","27607876, 25932848, 25248797, 20357374, 27459375, 26542419, 26375471, 28161306, 24060449, 22616913, 24002348"
67,Physical activity in pregnancy prevents gestational diabetes: A meta-analysis,Prevention of gestational diabetes,"(((""Diabetes, Gestational""[Mesh] OR Diabetes[tiab]) AND (""Pregnancy""[Mesh] OR Pregnancy[tiab] OR Pregnant[tiab] OR Pregnancies[tiab] OR Gestation[tiab] OR Gestational[tiab])) OR ((""Pregnancy""[Mesh] OR Pregnancy[tiab] OR Pregnant[tiab] OR Pregnancies[tiab] OR Gestation[tiab] OR Gestational[tiab]) AND (""Obesity""[Mesh] OR Obesity[tiab] OR Obese[tiab]))) AND (""Life Style""[Mesh] OR ""Insulin""[Mesh] OR Metformin[Mesh] OR ""Life Style Intervention""[tiab] OR ""Lifestyle Intervention""[tiab] OR “Exercise intervention”[tiab] OR Metformin[tiab] OR “Insulin sensitising”[tiab] OR “Lifestyle counseling”[tiab] OR “Glucose tolerance”[tiab] OR “Antenatal care “[tiab] OR “Dietary management”[tiab]) AND (""Treatment Outcome""[Mesh] OR ""Pregnancy Outcome""[Mesh] OR ""Pregnancy Complications""[Mesh] OR ""Morbidity""[Mesh] OR Prevention[tiab] OR Prevent[tiab] OR Preventing[tiab] OR “Insulin resistance”[tiab] OR Incidence[tiab] OR Prevalence[tiab] OR ((Improved[tiab] OR Adverse[tiab] OR Obstetric[tiab] OR Pregnancy[tiab]) AND (Outcome[tiab] OR Outcomes[tiab]))) ","27607876, 25932848, 25248797, 20357374, 27459375, 26542419, 26375471, 28161306, 24060449, 22616913, 24002348"
44,Blue-Light Therapy for Acne Vulgaris: A Systematic Review and Meta-Analysis,Blue light for acne,"(“Acne Vulgaris”[Mesh] OR Acne[tiab] OR Blackheads[tiab] OR Whiteheads[tiab] OR Pimples[tiab]) AND (""Phototherapy""[Mesh] OR “Blue light”[tiab] OR Phototherapy[tiab] OR Phototherapies[tiab] OR “Photoradiation therapy”[tiab] OR “Photoradiation Therapies”[tiab] OR “Light Therapy”[tiab] OR “Light Therapies”[tiab]) ","23278295, 10809858, 27762647, 27670126, 27575854, 27354885, 26897386, 26852728, 25594129, 10809858"
78,Is antimicrobial administration to food animals a direct threat to human health? A rapid systematic review,Antibiotic resistance in food animals,"(""Drug Resistance, Microbial""[Mesh] OR “Drug resistance”[tiab] OR “Drug resistant”[tiab] OR “multidrug-resistant”[tiab] OR “multidrug resistant”[tiab] OR “Microbial resistant”[tiab] OR “Microbial resistance”[tiab] OR “Antibiotic resistance”[tiab] OR “Antibiotic resistant”[tiab] OR “Antibacterial resistance”[tiab] OR “Antibacterial resistant”[tiab] OR “Antimicrobial resistance”[tiab] OR “Antimicrobial resistant”[tiab]) AND (""Anti-Bacterial Agents""[Mesh] OR ""Macrolides""[Mesh] OR ""beta-Lactams""[Mesh] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Methicillin[tiab] OR Ampicillin[tiab] OR Azithromycin[tiab] OR Cephalexin[tiab] OR Apramycin[tiab] OR Streptomycin[tiab]) AND (""Cattle""[Mesh] OR ""Swine""[Mesh] OR “Poultry”[Mesh] OR “Farm animals”[tiab] OR “Food animals”[tiab] OR “Food systems” OR Cattle[tiab] OR Beef[tiab] OR Swine[tiab] OR Pig[tiab] OR Pigs[tiab] OR Poultry[tiab] OR Chickens[tiab]) AND (""Microbial Sensitivity Tests""[Mesh] OR Isolates[tiab] OR Isolated[tiab] OR Samples[tiab] OR Strains[tiab] OR Strain[tiab] OR Carriage[tiab] OR Phylogenetic OR Metagenomic OR PCR OR Selects) AND (""Zoonoses""[Mesh] OR ""Animal Diseases""[Mesh] OR Zoonoses[tiab] OR Zoonotic[tiab] OR Transmitted[tiab] OR Transmission[tiab] OR Susceptibility[tiab] OR Susceptible[tiab] OR Selective[tiab] OR Selection[tiab]) ","25745868, 24655578, 18502931, 21504594, 25739516, 26472561, 15910233, 26258869, 21037885, 18469042, 19003784, 19822372, 19581058, 19025467, 10664974, 14632995, 24492576, 18417664, 24872333, 24260423, 26616601, 16151077, 3954347, 25506918, 18672961, 63311, 15297474, 24629774, 18223115, 9988049, 15309963, 19622032, 17472449, 19963297, 26074889, 17105560, 6994088, 16751491, 17557857, 25172121, 25548055, 24031659, 18644956, 19376926, 776049, 15715858, 10852562, 12643501, 1108781, 16238734, 4265554, 17002549, 26739225, 24919413, 16000800, 17199517, 27035748, 25769824, 23800604, 14766551, 16820447, 16366853, 8593153, 17803155, 17353243, 20497488, 24467930, 3710942, 21664077, 798179, 18723654, 21645183, 20408918, 16364022, 23320424, 1098010, 23750157, 18505210, 20617937, 25935558, 24982086, 26633649, 25098762, 25465547, 12118518, 20684867, 23793629, 22307299, 10347077, 21034271, 18322557, 12450826, 18950963, 24755996, 23024453, 26135895, 17194843"
88,Towards a better understanding of self-management interventions in type 2 diabetes: A meta-regression analysis,Group based interventions for type 2 diabetes,"(""Patient Education as Topic""[Mesh] OR ""Self Care""[Mesh] OR ""Behavior Therapy""[Mesh] OR ""Group Processes""[Mesh] OR ""Psychotherapy, Group""[Mesh] OR ""Self-Help Groups""[Mesh] OR Patient education[tiab] OR Self care[tiab] OR Self management[tiab] OR Behavior therapy[tiab] OR Behaviour therapy[tiab] OR Group process[tiab] OR Group processes[tiab] OR Group psychotherapy[tiab] OR ((Education[tiab] OR Educational[tiab] OR psychoeducational[tiab] OR Training[tiab] OR Teaching[tiab] OR Lifestyle[tiab]) AND (Programme[tiab] OR Programmes[tiab] OR Program[tiab] OR Programs[tiab]))) AND (""Diabetes Mellitus, Type 2""[Mesh] OR MODY[tiab] OR NIDDM[tiab] OR T2DM[tiab] OR ((non insulin[tiab] OR noninsulin[tiab] OR “Type 2”[tiab] OR “Type II”[tiab] OR Ketosis-Resistant[tiab] OR Ketosis resistant[tiab] OR Maturity-Onset[tiab] OR Maturity onset[tiab] OR Mature-onset[tiab] OR Mature onset[tiab] OR Adult-onset[tiab] OR Adult onset[tiab] OR Slow-onset[tiab] OR Slow onset[tiab] OR Stable[tiab]) AND Diabetes)) AND (Group[tiab] OR Groups[tiab] OR Participants[tiab]) NOT (""Diabetes Insipidus""[Mesh] OR Diabetes Insipidus[tiab])","16922700, 29858857, 20714820, 21605212, 29903525, 21812879, 26962749, 18849465, 18928196, 27477476, 23532298, 24152055, 20556536, 26304977, 30030158, 8401245, 24468198, 28330385, 21616627, 25584346, 23448107, 22762449, 17426305, 23393217, 20484125, 15919639, 24450992, 17469891, 7555554, 16524346, 12171451, 19383882, 26018099, 19131469, 18596303, 21986350, 30862659, 25125508, 26184986, 30963440, 24569698, 23219484, 23158845, 23174629, 21300516, 21775748, 21788632, 21378213, 21074887, 20675953, 17684167, 23816038, 20484058, 19707085, 19407333, 10414474, 18375778, 23453178, 16259492, 20299481, 21986347, 21680932, 17909165, 28447545, 24872385, 22127826, 16100331, 2357919, 29178317, 27897469, 17181082, 16629914, 28954789, 22414198, 27885969, 22539172, 18435777, 15089797, 28707567, 17289660, 31829220, 31683226, 30409669, 25499592, 21592715, 15186866, 17069923, 32471770, 19616166, 21143256, 28448779, 23844570, 19454403, 25724879, 19674176, 23985247, 24345601, 24963611, 25456892, 30283767, 29149618, 25136645, 23198694, 15569128, 28507433, 22092426, 20388042, 19171294, 12619168, 28599868, 21693570, 29731946, 31890682, 19566639, 27640303, 25113555, 25818472, 17470188, 23830727, 22971205, 28979737, 25075380, 24049598, 29435911, 29560148, 25761821, 27907074, 30456964, 29218127, 29357380, 30406070, 24766179, 25789518, 22008019, 19451553, 27253458, 27513247"
105,Self-Management for Men With Lower Urinary Tract Symptoms: A Systematic Review and Meta-Analysis,UTS Self management,"(""Lower Urinary Tract Symptoms""[Mesh] OR ""Prostatic Hyperplasia""[Mesh] OR ""Urinary tract symptoms""[tiab] OR LUTS[tiab] OR Dysuria[tiab] OR Nocturia[tiab] OR Prostatism[tiab] OR ""Overactive bladder""[tiab] OR ""Underactive bladder""[tiab] OR ""Urinary Incontinence""[tiab] OR ""Urinary Stress""[tiab] OR ""Urinary Urge""[tiab] OR ""Painful Urination""[tiab] OR ""Frequent Urination""[tiab] OR Nycturia[tiab] OR ""Urge Incontinence""[tiab] OR ""Prostatic Hypertrophy""[tiab] OR ""Prostatic Hyperplasia""[tiab] OR “Prostatic Adenomas”[tiab] OR “Prostatic Adenoma”[tiab]) AND ( ""Self Care""[Mesh] OR “Behavior Therapy”[Mesh] OR ""Life Style""[Mesh] OR ""Self care""[tiab] OR “Self management”[tiab] OR Self-management[tiab] OR SMP[tiab] OR Behavioral[tiab] OR Behavioural[tiab] OR ""Education“[tiab] OR “Fluid management""[tiab] OR ""Bladder retraining""[tiab] OR ""Bladder re-training”[tiab] OR “Toileting”[tiab] OR “Toilet training”[tiab] OR ""Fluid input""[tiab] OR ""Fluid manipulation""[tiab] OR Lifestyle[ti] OR “Life style”[ti] OR Lifestyles[ti] OR “Life styles”[ti] OR ((Avoid[tiab] OR Avoiding[tiab]) AND (Constipation[tiab])) OR ((""Fluid intake""[tiab]) AND (Increase[tiab] OR Increasing[tiab] OR Decrease[tiab] OR Decreasing[tiab] OR Modify[tiab] OR Modifying[tiab])) OR ((“Pelvic floor”[tiab]) AND (training[tiab] OR exercise[tiab] OR exercises[tiab])) ) ","17118949, 22482874, 28332234, 17113895, 22092152, 31930360, 28029383, 9202555"
4,Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis,Covid19 and asymptomatic rates,"((""COVID-19""[Supplementary Concept] OR “COVID-19”[tiab] OR COVID19[tiab] OR “COVID 19”[tiab] OR “SARS-CoV-2”[tiab] OR “2019-nCoV”[tiab] OR “Novel coronavirus”[tiab] OR “Coronavirus 2019”[tiab] OR “Coronavirus 19”[tiab] OR “COVID 2019”[tiab] OR ""2019 ncov""[tiab] OR “Wuhan coronavirus”[tiab])  AND (""Asymptomatic Diseases""[Mesh] OR Asymptomatic[tiab] OR Presymptomatic[tiab] OR “Pre-Symptomatic”[tiab] OR “No symptoms”[tiab] OR “No symptom”[tiab] OR “Silent transmission”[tiab] OR “Silent carrier”[tiab] OR “Silent carriers”[tiab] OR Asymptomatic[ti] OR Presymptomatic[ti] OR “Pre-Symptomatic”[ti])) ","32271726, 32548628, 32463809, 32674822, 32329971, 32453686, 33794836, 32356867, 32604404, 32353347, 32324530"
12,Use of methenamine hippurate to prevent urinary tract infections in community adult women: a systematic review and meta-analysis,Hiprex for UTIs,"(""Urinary Tract Infections""[Mesh] OR ""Cystitis""[Mesh] OR ""Bacteriuria""[Mesh] OR “Urinary Tract Infections”[tiab] OR “Urinary Tract Infection”[tiab] OR UTIs[tiab] OR UTI[tiab] OR Cystitis[tiab] OR Bacteriuria[tiab]) AND (""Methenamine hippurate""[Supplementary Concept] OR ""Methenamine""[Mesh] OR ""Hippurates""[Mesh] OR Hexamine[tiab] OR Hippurate[tiab] OR Hippurates[tiab] OR Urex[tiab] OR Hiprex[tiab] OR Hip-Rex[tiab] OR Urotractan[tiab] OR Hexamethylenetetramine[tiab] OR Methenamine[tiab] OR Urotropin[tiab] OR Aminoform[tiab] OR “Hippuric acid”[tiab])  ","7019458, 6227756, 1099490, 3535165, 6377577, 34115162"
2,Effect of different visual presentations on the comprehension of prognostic information: a systematic review,Communication of natural course or prognosis of diseases,"(""Prognosis""[Mesh] OR “Natural history”[tiab] OR “Natural course”[tiab] OR “Clinical course”[tiab] OR “Watchful waiting”[tiab] OR ((Symptom[tiab] OR Symptoms[tiab]) AND (Duration[tiab])) OR “Wait and see”[tiab] OR “Active monitoring”[tiab] OR Prognosis[tiab]) AND (Communication[tiab] OR Communicate[tiab] OR Framing[tiab] OR Discuss[tiab] OR “Shared decision making”[tiab] OR Presented[tiab] OR Perceptions[tiab] OR Perceive[tiab] OR Perceived[tiab]) AND (""Decision Support Techniques""[Mesh] OR ""Decision Making""[Mesh] OR ""Decision Making, Shared""[Mesh] OR “Decision aid”[tiab] OR “Decision tool”[tiab] OR Decision[tiab] OR Decisions[tiab]) AND (Graph[tiab] OR Graphs[tiab] OR Graphic[tiab] OR Graphics[tiab] OR Graphical[tiab] OR Chart[tiab])  ","11833668, 32269779, 25277673, 27981688, 26044208, 30799691, 19012353, 17137743, 20375419"
3,Does copper treatment of commonly touched surfaces reduce healthcare-acquired infections? A systematic review and meta-analysis,Copper for superbugs,"(""Copper""[Mesh] OR Copper[tiab]) AND (""Infections""[Mesh] OR ""Equipment Contamination""[Mesh] OR ""Infection Control""[Mesh] OR ""Cross Infection""[Mesh] OR Infection[tiab] OR Infections[tiab] OR Colonization[tiab]) AND (""Health Facilities""[Mesh] OR Hospital[tiab] OR Hospitals[tiab] OR “Healthcare facility”[tiab] OR “Healthcare facilities”[tiab] OR  “Intensive care”[tiab] OR “Intensive-care”[tiab] OR ICU[tiab] OR PICU[tiab] OR Ward[tiab] OR Wards[tiab]) ","28034536, 32068014, 26163568, 25146200, 23571364, 27692785, 27318524, 30954421, 23571364, 28034536"
10,Head of bed elevation to relieve gastroesophageal reflux symptoms: a systematic review,Head of bed (Sleep) positioning for Gastroesophageal Reflux Disease (GERD): a systematic review,"(""Gastroesophageal Reflux""[Mesh] OR ""Esophagitis""[Mesh] OR ""Heartburn""[Mesh] OR ""Dyspepsia""[Mesh] OR ""Duodenogastric Reflux""[Mesh] OR Reflux[tiab] OR GERD[tiab] OR Oesophagitis[tiab] OR Esophagitis[tiab] OR Heartburn[tiab] OR “Heart burn”[tiab] OR GORD[tiab] OR Dyspepsia[tiab] OR Dyspepsias[tiab] OR Indigestion[tiab] OR Indigestions[tiab]) AND (""Sleep""[Mesh] OR Sleep[tiab] OR Sleeping[tiab] OR Bed[tiab] OR Bed-Head[tiab] OR Bed-up[tiab] OR Bedrest[tiab] OR Bed-rest[tiab] OR Nocturnal[tiab] OR Wedge[tiab]) AND (""Patient Positioning""[Mesh] OR ""Supine Position""[Mesh] OR Positioning[tiab] OR Position[tiab] OR Supine[tiab] OR Elevation[tiab] OR Elevated OR Raised[tiab] OR Semi-recumbent[tiab] OR Semireclined[tiab] OR Semi-reclined[tiab] OR “Semi reclined”[tiab] OR Left-side[tiab] OR Right-side[tiab] OR Side[tiab] OR Lateral[tiab]) ","32229033, 31868819, 3359906, 2890820, 14044"
13,A catalogue of tools and variables from crisis and routine care to support decision-making about allocation of intensive care beds and ventilator treatment during pandemics: Scoping review,ICU ventilator allocation,"(""Resource Allocation""[Mesh] OR Resource[tiab] OR Resources[tiab] OR Allocation[tiab] OR Demand[tiab] OR “Prognostic certainty”[tiab] OR “External validation”[tiab] OR Prognosticative[tiab] OR Prognosticating[tiab] OR “Validation cohort”[tiab]) AND (“Decision rule”[tiab] OR “Decision Support”[tiab] OR Prediction[tiab] OR Predictions[tiab] OR Predictor[tiab] OR Predicting[tiab] OR Predictive[tiab] OR “Scoring systems”[tiab] OR “Scoring system”[tiab] OR “Decision making”[tiab] OR “Preparedness strategies”[tiab] OR “Preparedness strategy”[tiab] OR “Prioritization Criteria”[tiab] OR “Prioritizing access”[tiab] OR “Consensus Statement”[tiab] OR “Categorization decisions”[tiab] OR “Allocation decisions”[tiab] OR “Clinical guidelines”[tiab]) AND (""Triage""[Mesh] OR ""Patient Selection""[Mesh] OR Triage[tiab] OR Triaging[tiab] OR Admission[tiab] OR Discharge[tiab] OR “Incident management”[tiab] OR “Treatment priority”[tiab] OR “Patient volumes”[tiab] OR ((Managing[tiab]) AND (Cohort[tiab])) OR (Calculators[tiab] AND Patients[tiab])) AND (""Emergency Medical Services""[Mesh] OR ""Critical Care""[Mesh] OR ""Intensive Care Units""[Mesh] OR “Intensive care”[tiab] OR “Critical care”[tiab] OR ICU[tiab] OR PICU[tiab] OR “Critically ill”[tiab] OR “Life saving”[tiab] OR Life-saving[tiab] OR Life-sustaining[tiab] OR “Life sustaining”[tiab] OR “Life support”[tiab] OR “Short-term death”[tiab] OR “Short term death”[tiab] OR “Death prediction”[tiab] OR Hospital[tiab] OR Hospitals[tiab] OR “Emergency department”[tiab] OR “Emergency departments”[tiab]) AND (""Pandemics""[Mesh] OR Disasters[Mesh] OR ""Hospital Mortality""[Mesh] OR ""COVID-19""[nm] OR Pandemic[tiab] OR Pandemics[tiab] OR Disaster[tiab] OR Disasters[tiab] OR “SARS CoV 2”[tiab] OR “COVID 19”[tiab] OR “COVID-19”[tiab] OR “Mass casualty”[tiab] OR “Severe sepsis”[tiab] OR “Septic shock”[tiab] OR ""Short-term mortality”[tiab]) ","32289312, 17116904, 18460506, 32660660, 18388654, 19153413, 32803751, 32369433, 20213418, 32426441, 33715144, 32442528, 21269458, 21149228, 19825055, 19860754, 32396163, 24069409, 17417099, 22700021, 33296357, 33894209, 33454051, 33988767, 34136826, 33546711, 33149652, 32616597, 33888856, 33355697, 33117852, 30316913, 27484461, 29368381, 28991830, 22189727, 12541154, 15678308, 17318745, 18558884, 18787440, 26247337, 31723643, 33323232, 25318386, 22584761, 23787145, 21926598, 29179764, 22685695, 26903338, 32188656, 20146829, 16973986, 30910912, 31616192, 26147765, 22805170, 22401951, 17046859, 20849009, 24970344, 23782899, 30574216, 32251482, 17451605, 25778109, 12728155, 24383430, 25144186, 23552435, 26054605"
66,Challenges and facilitators in delivering optimal care at the End of Life for older patients: a scoping review on the clinicians' perspective,Possible bias in reporting consumer perspectives in medical studies of older patients near the end of life. A scoping review,"(Aged[Mesh] OR Elderly[tiab] OR Older[tiab] OR decision-makers[tiab] OR Surrogates[tiab] OR Patients[tiab] OR Carers[tiab]) AND (“Terminal Care”[Mesh] OR ""Palliative Care""[Mesh] OR “Frail Elderly”[Mesh] OR “End of life”[tiab] OR “Last year of life”[tiab] OR “Limited life”[tiab] OR Frail[tiab] OR Death[tiab] OR Dying[tiab] OR Palliative[tiab] OR “Intensive care”[tiab]) AND (""Patient Preference""[Mesh] OR Perception[tiab] OR perspective[tiab] OR perceived[tiab] OR experience[tiab] OR Experiences[tiab] OR opinion[tiab] OR views[tiab] OR satisfaction[tiab] OR discordance[tiab] OR discrepancy[tiab] OR dissonance[tiab]) AND (Consultation[tiab] OR Communication[tiab] OR “focus groups”[tiab] OR “Focus group”[tiab]) ","25390467, 27815169, 25892177, 23453467, 21631874, 22079261, 24524547, 30868725, 24644187, 25615833, 19549336, 27169558"
14,Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review,"Impact of Covid-19 on hospital systems (admissions, elective surgeries etc.)","(""COVID-19""[Supplementary Concept] OR “COVID-19”[tiab] OR COVID19[tiab] OR “COVID 19”[tiab] OR “SARS-CoV-2”[tiab] OR “2019-nCoV”[tiab] OR “Novel coronavirus”[tiab] OR “Coronavirus 2019”[tiab] OR “Coronavirus 19”[tiab] OR “COVID 2019”[tiab] OR ""2019 ncov""[tiab] OR “Wuhan coronavirus”[tiab]) AND (((Pandemic[ti] OR Pandemics[ti] OR Outbreak[ti] OR Outbreaks[ti] OR Hospital[ti] OR Hospitals[ti] OR Emergency[ti] OR Surgery[ti] OR Surgical[ti] OR Department[ti] OR Departments[ti] OR Unit[ti] OR Units[ti] OR Clinic[ti] OR Clinics[ti] OR “Primary care”[ti]) AND (Admission[ti] OR Admissions[ti] OR Visit[ti] OR Visits[ti] OR Attendance[ti] OR Attending[ti] OR Activity[ti] OR Utilization[ti] OR Utilisation[ti] OR Impact[ti] OR Impacts[ti] OR Reduction[ti] OR Reductions[ti] OR Decrease[ti] OR Decreases[ti] OR Decreased[ti] OR Decline[ti] OR Decline[ti] OR Change[ti] OR Changes[ti] OR Increase[ti] OR Increases[ti] OR Increased[ti])) OR ((Pandemic[tiab] OR Pandemics[tiab] OR Outbreak[tiab] OR Outbreaks[tiab]) AND (((Hospital[tiab] OR Hospitals[tiab] OR Emergency[tiab] OR Surgery[tiab] OR Surgical[tiab] OR Department[tiab] OR Departments[tiab] OR Unit[tiab] OR Units[tiab] OR Clinic[tiab] OR Clinics[tiab] OR “Primary care”[tiab] OR Telemedicine[tiab] OR Telehealth[tiab]) AND (Admission[tiab] OR Admissions[tiab] OR Visit[tiab] OR Visits[tiab] OR Attendance[tiab] OR Attending[tiab] OR Activity[tiab] OR Utilization[tiab] OR Utilisation[tiab])) OR (Prescriptions[tiab] OR Prescribed[tiab] OR Vaccinations[tiab] OR Imaging[tiab] OR Scans[tiab] OR Endoscopy[tiab] OR Endoscopic[tiab] OR Endoscopies[tiab])) AND (Impact[tiab] OR Impacts[tiab] OR Reduction[tiab] OR Reductions[tiab] OR Decrease[tiab] OR Decreases[tiab] OR Decreased[tiab] OR Decline[tiab] OR Declines[tiab] OR Changes[tiab] OR Increase[tiab] OR Increases[tiab] OR Increased[tiab]))) ","32482087, 33501967, 32713658, 32590109, 32501493, 32591960, 32502261, 32658846, 32569892, 32437340, 33208182, 32679205, 32705775, 32663615, 32727305, 32368994, 32881180, 32343497, 32511563, 32412631, 32530738, 32482976, 32533248, 32497912, 32682855, 32767652, 32710908, 32684717, 32378325, 32525856, 32504280, 32516064, 32376695, 32755347, 32665133, 32432994, 32637995, 32737912, 32594089, 32555723, 32734936, 32636131, 32679176, 32278365, 32713656, 32425228, 32679111, 32573026, 32525290, 32431288, 32748481, 32425710, 32717183, 32407585, 32478606, 32691901, 32609417, 32430140, 32399995, 32618967, 32348457, 32451301, 32565077, 32615891, 34812731, 32461213, 32676681, 32447060, 32749558, 32505472, 32445768, 32730468, 32838107, 32675668, 32740067, 32432997"
1,Downsides of face masks and possible mitigation strategies: a systematic review and meta-analysis,Adverse effects of masks,"((""Masks/adverse effects""[MAJR]) OR ((Masks[Mesh] OR ""Respiratory protective devices""[Mesh] OR Facemask[tiab] OR Facemasks[tiab] OR Mask[tiab] OR Masks[tiab] OR Faceshield[tiab] OR Faceshields[tiab] OR Goggles[tiab] OR “Face shield”[tiab] OR “Face shields”[tiab] OR Visors[tiab] OR “Face covering”[tiab]) AND (""Adverse effects""[sh] OR “Adverse effect”[tiab] OR “Adverse effects”[tiab] OR “Adversely affect”[tiab] OR “Adverse event”[tiab] OR “Adverse events”[tiab] OR Discomfort[tiab] OR Fatigue[tiab] OR Pain[tiab] OR “Difficulty breathing”[tiab] OR “Breathing difficulty”[tiab] OR “Shortness of breath”[tiab] OR “Risk compensation”[tiab] OR Fomite[tiab] OR Fomites[tiab] OR Dislike[tiab] OR “Physiological impacts”[tiab] OR “Physiological impact”[tiab] OR Sweating[tiab] OR Irritation[tiab] OR “Psychological reactions”[tiab] OR Fear[tiab] OR Communication[tiab] OR “Deaf persons”[tiab] OR Lip-reading[tiab] OR “Lip reading”[tiab] OR Vitiligo[tiab] OR Humidity[tiab] OR “Face dermatitis”[tiab] OR Acne[tiab] OR Redness[tiab] OR Ulcer[tiab] OR “Speech understanding”[tiab] OR “Pinching of skin”[tiab] OR “Moisture buildup”[tiab] OR “Facial warmth”[tiab]) AND (Relieve[tiab] OR Attitudes[tiab] OR Induced[tiab] OR Modified[tiab] OR Decreased[tiab] OR Decrease[tiab] OR Associated[tiab] OR Impair[tiab] OR Reduce[tiab] OR Reducing[tiab] OR Reduced[tiab] OR Duration[tiab]))) NOT (""Continuous Positive Airway Pressure""[Mesh] OR ""Positive Airway Pressure""[tiab] OR CPAP[tiab] OR ""Laryngeal Masks""[Mesh] OR ""Intubation, Intratracheal""[Mesh] OR “Oxygen masks”[tiab] OR “Oxygen mask”[tiab] OR OxyMask[tiab] OR “Nasal masks”[tiab] OR “Patil-Syracuse Mask”[tiab] OR “Ventilation masks”[tiab] OR “Venti-Mask”[tiab] OR “Venturi mask”[tiab] OR “Diving masks”[tiab] OR “Thermoplastic masks”[tiab] OR Bag-valve-mask[tiab] OR “Laryngeal mask”[tiab] OR “Laryngeal masks”[tiab] OR “Oronasal masks”[tiab] OR “Sleep mask”[tiab] OR Editorial[pt] OR Letter[pt] OR “Case reports”[pt]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]))","22295066, 20836797, 20036443, 25336079, 18295373, 21103330, 26980847, 31159777, 19652172, 18461182, 21198810, 17026695, 19216002, 15340662, 20297744, 21893677, 16441251, 19193267, 25903751, 21477136, 23413265, 22503134, 14993174, 32232837, 29322580, 29395560, 19126810, 31479137, 22326638, 23768438, 22168256, 21651736, 21211103, 22280120, 21382570, 16581214, 32432708, 24364989"
32,The effectiveness of telehealth versus face-to face interventions for anxiety disorders: A systematic review and meta-analysis,Telehealth consults vs face to face consults - general mental health,"(""Telemedicine""[Mesh] OR ""Videoconferencing""[Mesh] OR Telehealth[tiab] OR Telemedicine[tiab] OR Videoconferencing[tiab] OR ((Telephone[tiab]) AND (Consultation[tiab] OR face-to-face[tiab] OR in-person[tiab])) OR telephone-delivered[tiab]) AND (""Primary Health Care""[Mesh] OR ""General Practice""[Mesh] OR rehabilitation[sh] OR ""Outpatients""[Mesh] OR ""Speech Therapy""[Mesh] OR Outpatient[tiab] OR “Primary health”[tiab] OR “Primary care”[tiab] OR “General practice”[tiab] OR “General practices”[tiab] OR “General practitioners”[tiab] OR “General practitioner”[tiab] OR “Family practice”[tiab] OR Physician[tiab] OR Physicians[tiab] OR Clinician[tiab] OR Clinicians[tiab] OR Therapist[tiab] OR Nurse[tiab] OR Nurses[tiab] OR Physiotherapist[tiab] OR Rehabilitation[tiab] OR Diabetes[tiab] OR Diabetic[tiab] OR Asthma[tiab] OR Depression[tiab] OR “Ïrritable bowel”[tiab] OR IBS[tiab] OR PTSD[tiab] OR “Chronic fatigue”[tiab]) AND ((Face to face[tiab]) OR “Usual care”[tiab] OR Visits[tiab] OR Visit[tiab] OR In-person[tiab] OR “In person”[tiab] OR ((Clinic[tiab] OR Centre[tiab] OR Home[tiab]) AND (Based[tiab] OR Contact[tiab])) OR Conventional[tiab] OR “Practice-based”[tiab] OR “Practice based”[tiab] OR Traditional[tiab] OR “Standard care”[tiab] OR Homecare[tiab] OR ((Routine[tiab] OR Home[tiab]) AND (Care[tiab]))) AND (""Delivery of Health Care""[Mesh] OR Delivery[tiab] OR Delivered[tiab] OR Via[tiab] OR Received[tiab]) AND (""Treatment Outcome""[Mesh] OR ""Patient Satisfaction""[Mesh] OR Therapy[sh] OR Diagnosis[sh] OR “Clinical outcomes”[tiab] OR Treatment[tiab] OR Diagnostic[tiab] OR Efficacy[tiab]) ","16935946, 27869451, 25457928, 24252663"
210,Postpartum Care for Women Up to One Year After Pregnancy,"Key Question 1: What healthcare delivery strategies affect postpartum healthcare utilization and improve maternal outcomes within 1 year postpartum? a. Do the healthcare delivery strategies affect postpartum healthcare utilization and improve maternal outcomes within 3 months postpartum? Does this relationship differ by timing of outcomes, specifically within 6 days postpartum, between 1 to 6 weeks postpartum, and between 6 weeks and 3 months postpartum? b. Do the healthcare delivery strategies affect postpartum healthcare utilization and improve maternal outcomes between 3 months and 1 year postpartum? Key Question 2:  Does extension of health insurance coverage or access to healthcare affect postpartum healthcare utilization and improve maternal outcomes within 1 year postpartum?","(((postpartum[tiab] OR post-partum[tiab] OR postnatal[tiab] OR post-natal[tiab] OR puerperal[tiab] OR puerperium[tiab] OR postdelivery[tiab] OR post-delivery[tiab] OR ""post delivery""[tiab] OR ""Peripartum Period""[Mesh] OR ""fourth trimester""[tiab] OR ""4th trimester""[tiab]) AND (""Perinatal Care""[Mesh] OR ""Postnatal Care""[Mesh] OR ""care coordination""[tiab] OR ""care co-ordination"" [tiab] OR ""coordination of care""[tiab] OR ""co-ordination of care""[tiab] OR ""Case Management""[Mesh] OR ""Coordinated care""[tiab] OR ""Co-ordinated care""[tiab] OR ""collaborative care""[tiab] OR ""integrated care""[tiab] OR ""shared care""[tiab] OR ""transitional care""[tiab] OR ""comanagement""[tiab] OR ""co-management""[tiab] OR ""case management""[tiab] OR ""multidisciplinary care""[tiab] OR ""interdisciplinary care""[tiab] OR ""disease management""[tiab] OR ""Progressive Patient Care""[MeSH] OR ""Continuity of Patient Care""[MeSH] OR ""Patient-Centered Care""[MeSH] OR ""Patient Care Planning""[MeSH] OR ""Disease Management""[MeSH] OR ""Delivery of Health Care, Integrated""[MeSH] OR ""Delivery of Health Care ""[Mesh] OR ""Standard of Care""[Mesh] OR ""Health Services Accessibility""[Mesh] OR ""Appointments AND Schedules""[Mesh] OR ((care OR treatment) AND (timing OR integrat* OR collaborat* OR coordinat* OR transition* OR interdisciplin* OR shared OR comanagement OR cooperat* OR aftercare OR interinstitution* OR synchron* OR harmon* OR manage*)) OR ""Office Visits""[Mesh] OR ""office visits""[tiab] OR Doula[tiab] OR Midwife[tiab] OR ""Home visit*""[tiab] OR ""home-visit*""[tiab] OR ""group visit""[tiab] OR ""support group""[tiab] OR centering[tiab] OR holistic[tiab] OR ((""Lay support"" OR Outreach OR ""community health"") AND worker) OR ""Patient navigator""[tiab] OR ""Telemedicine""[Mesh] OR ""Remote Consultation""[Mesh] OR ehealth[tiab] OR e-health*[tiab] OR mhealth*[tiab] OR m-health*[tiab] OR telemedicine[tiab] OR telehealth[tiab] OR telecare[tiab] OR smartphone*[tiab] OR ""smart phone*""[tiab] OR ""smart-phone*""[tiab] OR ""cell phone*""[tiab] OR ""mobile phone*""[tiab] OR ((remote* OR video OR virtual OR phone) AND (care OR consult* OR visit* OR service*)) OR ""remote monitoring""[tiab] OR Telemonitoring[tiab] OR wearable[tiab] OR wireless[tiab] OR portable[tiab] OR ""Health education""[tiab] OR Contracept*[tiab] OR insurance expansion[tiab] OR Medicaid expansion[tiab] OR ""Maternal Death/prevention AND control""[MESH] OR ""Maternal-Child Health Services""[Mesh]))) ","2328162, 9170692, 9924864, 10790463, 10882317, 11155608, 11519238, 11533342, 11755800, 11800243, 12042545, 12515413, 12657988, 12675164, 15351756, 16143742, 17557933, 17558823, 18692614, 19147637, 19551471, 19854119, 20958105, 20966692, 21365543, 21466755, 21485419, 21843688, 22018124, 22064874, 22488220, 22535790, 23209111, 23218851, 24019052, 24187119, 24262719, 24354834, 24354834, 24457061, 24631431, 25092936, 25193602, 25627330, 26779838, 26871448, 27423234, 27936990, 28697099, 29325660, 29490290, 29530670, 29778586, 29855838, 30414598, 30484739, 31158852, 31397625, 31629118, 31905073, 31964564, 32656692, 32739716, 32958368, 33078655, 33082990, 33136489, 33523747, 33655429, 33785465, 33849768, 34109490, 34606358, 34619694, 34670222, 34671758"
211,"A Systematic Review of Postpartum Home Blood Pressure Monitoring, Postpartum Treatment of Hypertensive Disorders of Pregnancy, and Peripartum Magnesium Sulfate Regimens for Preeclampsia With Severe Features","KQ 1: What are the effectiveness, comparative effectiveness, and harms of home blood pressure monitoring/telemonitoring in postpartum individuals? KQ 2: What are the effectiveness, comparative effectiveness, and harms of pharmacological treatments for hypertensive disorders of pregnancy in postpartum individuals? KQ 3: What are the comparative effectiveness and harms of alternative l magnesium sulfate treatment regimens to treat preeclampsia with severe features during the peripartum period? 3.a. Are there harms associated with the concomitant use of particular antihypertensive medications during treatment with magnesium sulfate?","(((postpartum OR post-partum OR postnatal OR post-natal OR puerperal OR puerperium OR postdelivery OR post-delivery OR ""post delivery"" OR Peripartum OR Peri-partum OR ""Perinatal Care""[Mesh] OR ""Postnatal Care""[Mesh] OR ""Peripartum Period""[Mesh] OR breastfeeding OR ""breast feeding"" OR lactation OR ""Breast Feeding""[Mesh] OR ""Lactation""[Mesh]) AND (Hyperten* OR ""Hypertension""[Mesh] OR ""high blood pressure"" OR pre-eclampsia OR eclampsia OR ""Pre-Eclampsia""[Mesh] OR ""Eclampsia""[Mesh] OR HELLP syndrome OR ""HELLP Syndrome""[Mesh] OR ""Antihypertensive Agents""[Mesh] OR Antihypertensive* OR Anti-hypertensive* OR ""Anti hypertensive*"" OR ""Blood Pressure Monitoring, Ambulatory""[Mesh] OR ((""blood pressure""[All Fields] AND (monitor* OR determin*)))) OR (((postpartum OR post-partum OR postnatal OR post-natal OR puerperal OR puerperium OR postdelivery OR post-delivery OR ""post delivery"" OR Peripartum OR Peri-partum OR ""Perinatal Care""[Mesh] OR ""Postnatal Care""[Mesh] OR ""Peripartum Period""[Mesh] OR ""Prenatal Care""[Mesh] OR ""Pregnancy""[Mesh] OR ""Pregnant Women""[Mesh] OR ""Pregnancy Trimesters""[Mesh] OR pregnancy OR pregnant OR antenatal OR ante-natal OR pregnancies OR prenatal OR pre-natal OR obstetrics OR gestation OR breastfeeding OR ""breast feeding"" OR lactation OR ""Breast Feeding""[Mesh] OR ""Lactation""[Mesh]) AND (Hyperten* OR ""Hypertension""[Mesh] OR ""high blood pressure"" OR pre-eclampsia OR eclampsia OR HELLP syndrome OR ""Hypertension, Pregnancy-Induced/physiopathology""[Mesh]) AND (Magnesium OR ""Magnesium Sulfate""[Mesh])))) OR (((eclampsia OR ""Eclampsia""[Mesh] OR HELLP syndrome OR ""HELLP Syndrome""[Mesh]) AND ((home) AND (""blood pressure"" OR ""blood-pressure"") AND monitoring)))) ","1951552, 2180472, 2316590, 2317464, 2789542, 7171513, 7485324, 7900522, 7980301, 8517903, 8868017, 9532990, 9790377, 9926482, 10533328, 10699198, 12057549, 12214831, 12517647, 12540643, 15113445, 15625138, 15970809, 16411990, 17012443, 17166220, 17166221, 17368649, 17469006, 19149977, 20132023, 21154341, 21534749, 21744767, 21798536, 22261127, 22930148, 23530757, 23691692, 23899372, 24069775, 24890747, 25483417, 26104987, 26364667, 26498603, 26604159, 27786578, 27835048, 28125624, 28475431, 28714170, 28738788, 28969211, 28974124, 29114367, 29453467, 29703800, 29878650, 29901967, 29967037, 29976161, 30303905, 30372830, 30823948, 30825917, 31121137, 31393402, 31489020, 31503166, 31641005, 31833059, 31889791, 32063925, 32439388, 32517785, 32774912, 32980623, 33012200, 33156201, 33179549, 33550824, 33607957, 34176288, 34329800, 34397475, 34470135, 34520145, 35283352, 35304745"
212,Schedule of Visits and Televisits for Routine Antenatal Care: A Systematic Review,"KQ 1: What are the benefits and harms of different antenatal care schedules that vary by number or timing of visits for pregnancies requiring routine care and monitoring? KQ 2: What are the benefits and harms of televisits for providing routine antenatal care during pregnancy? KQ 3: What are patient, partner/family, and provider perspectives, preferences, and experiences related to (a) antenatal care visit schedules and (b) use of televisits for routine antenatal care?","(((""Prenatal Care""[Mesh] OR ""Pregnancy""[Mesh] OR ""Pregnant Women""[Mesh] OR ""Pregnancy Trimesters""[Mesh] OR pregnancy OR pregnant OR antenatal OR ante-natal OR pregnancies OR prenatal OR pre-natal OR obstetrics OR gestation) AND (""Prenatal Care/organization AND administration""[Mesh] OR ""Continuity of Patient Care/standards""[Mesh] OR ""Delivery of Health Care/methods""[Mesh] OR ""Office Visits""[Mesh] OR “standard of Care""[Mesh] OR appointment* OR visit*) AND (""Appointments AND Schedules""[Mesh] OR ((number OR frequency OR cadence OR schedule) AND (Visit* OR Appointment* OR ""Office Visits""[Mesh])) OR Schedule*)) OR ((""Prenatal Care""[Mesh] OR ""Pregnancy""[Mesh] OR ""Pregnant Women""[Mesh] OR pregnancy OR pregnant OR antenatal OR ante-natal OR pregnancies OR prenatal OR pre-natal OR obstetrics) AND (""Telemedicine""[Mesh] OR ""Remote Consultation""[Mesh] OR ehealth OR e-health* OR mhealth* OR m-health* OR telemedicine OR telehealth OR smartphone* OR “smart phone*"" OR “smart-phone*"" OR ""cell phone*"" OR ""mobile phone*"" OR ((remote* OR video OR virtual) AND (care OR consult* OR visit* OR service*)) OR ""remote monitoring"" OR Telemonitoring OR wearable OR wireless OR portable))) ","7473439, 7616860, 8595286, 8596222, 9207816, 9277060, 9578278, 10426245, 10554744, 10688505, 10947550, 11028575, 11216259, 16322418, 24117000, 26474477, 26631000, 28176034, 31042154, 31198524, 31228414, 31928505, 32268713, 32516816, 33038898, 33039393, 33302251, 33478433, 33852002, 34217399, 34254940, 34498838, 35039177"
213,Nonsurgical Treatments for Urinary Incontinence in Women: A Systematic Review Update,"Key Question 1: What are the benefits and harms of nonpharmacological treatments of UI in women, and how do they compare with each other? Key Question 2: What are the benefits and harms of pharmacological treatments of UI in women, and how do they compare with each other? Key Question 3: What are the comparative benefits and harms of nonpharmacological versus pharmacological treatments of UI in women? Key Question 4: What are the benefits and harms of combined nonpharmacological and pharmacological treatment of UI in women?","(((""Urinary Bladder, Overactive""[Mesh] OR ""Urinary Incontinence""[Mesh] OR ""Enuresis""[Mesh] OR overactive bladder OR ((bladder or urine) AND incontinen*) OR enuresis OR nocturia OR ""Nocturia""[Mesh] OR ((bladder or urine or urina*) AND (overactive or incontinence or urgent or urgency or frequent or frequency or detrusor or leak*)) OR detrusor instability OR ""Urinary Bladder, Neurogenic""[Mesh] OR (bladder AND (neurogen* or neurologic*)) OR ""Urinary Incontinence, Urge""[Mesh] OR ""Urinary Incontinence, Stress""[Mesh] OR ((urine OR urina* or bladder*) AND urge*)) AND (""Urinary Incontinence/Radiotherapy""[Mesh] OR ""Urinary Incontinence/Rehabilitation""[Mesh] OR ""Urinary Incontinence/Surgery""[Mesh] OR ""Urinary Incontinence/Therapy""[Mesh] OR ""Urinary Incontinence/Diet Therapy""[Mesh] OR ""Urinary Incontinence/Nursing""[Mesh] OR ""Urinary Incontinence/drug therapy""[Mesh] OR ((non pharmacologic* or nonpharmacologic*) AND ""Treatment Outcome""[Mesh]) OR mirabegron OR ""Adrenergic beta-3 Receptor Agonists""[Mesh] OR Resiniferatoxin OR ""Botulinum Toxins""[Mesh] OR ""Botulinum Toxins, Type A""[Mesh] OR botulinum OR botox OR estrogen* OR ""Estrogens""[Mesh] OR Antimuscarinics OR oxybutynin chloride OR trospium chloride OR darifenacin OR solifenacin succinate OR fesoterodine OR tolterodine OR propiverine OR ""Calcium Channel Blockers""[Mesh] OR Calcium Channel Blocker* OR nimodipine OR TRPV1 antagonists OR resiniferatoxin OR Tricyclic antidepressant* OR Tricyclic anti-depressant OR ""Antidepressive Agents, Tricyclic""[Mesh] OR imipramine OR Beta 3 adeno-receptor agonists OR mirabegron OR ""Neuromuscular Agents""[Mesh] OR neuromuscular agents OR ((pelvic floor or bladder) AND (train* or exercise or physical therapAy)) OR kegel OR ""Physical Therapy Modalities""[Mesh] OR physiotherapy OR biofeedback OR ""Biofeedback, Psychology""[Mesh] OR electric* stimulation OR ""Electric Stimulation""[Mesh] OR nerve stimulation OR ""Transcutaneous Electric Nerve Stimulation""[Mesh] OR stoller OR ""Electrodes, Implanted""[Mesh] OR vesical pacing OR interstim OR ""fluid therapy""[Mesh] OR (fluid AND (therapy or manage*)) OR urge suppression OR ""Behavior Therapy""[Mesh] OR ((behavior* or behaviour*) AND (therapy or modif* or treat*)) OR ""hypnosis""[Mesh] OR (hypnosis or hypnotherapy) OR ""Drinking Behavior""[Mesh] OR ""Complementary Therapies""[Mesh] OR ((alternative or complementary) AND (therapy or treatment)) OR ""diet""[Mesh] OR diet OR dietary OR Vaginal cone* OR bladder support* OR (Urethra* AND (Plug or patch)) OR Pessar* OR Magnetic stimulation OR ""Magnetic Field Therapy""[Mesh] OR Urethral bulking OR ((transurethral or periurethral) AND injection*) OR Posterior tibial nerve stimulation OR neuromodulation OR Coaptite OR (Vaginal AND (cone* OR weight*)) OR Impressa OR Macroplastique implants OR Milnacipran OR Savella OR Trospium OR Sanctura OR Onabotulinum toxin A OR Botox OR Paroxetine OR Paxil OR Mirabegron OR Myrbetriq OR solifenacin succinate OR vesicare OR Amitriptyline OR Elavil OR Rimabotulinum toxin B OR Myobloc OR Fluoxetine OR Prozac OR Duloxetine OR Cymbalta OR Citalopram OR Celexa OR Escitalopram OR Lexapro OR Levomilnacipran OR Fetzima OR AbobotulinumtoxinA OR Dysport OR oxybutynin chloride OR Ditropan OR Fluvoxamine OR Luvox CR OR Imipramine OR Tofranil OR Nortriptyline OR Pamelorl OR Clomipramine OR Anafranil OR IncobotulinumtoxinA OR Xeomin OR Doxepin OR Silenor OR Protriptyline OR Vivactil OR Trimipramine OR Surmontil OR 5-HT2 receptor antagonist OR Doxepin OR Silenor OR Sertraline OR Zoloft OR Tolterodine OR Detrol OR Desipramine OR Pertofrane OR A-2 Desipramine OR Norpramin OR Darifenacin OR Enablex OR Desvenlafaxine OR Pristiq OR Topical estrogen OR premarin OR synthetic conjugated estrogens)))","20848671, 20886571, 21284022, 21351127, 21545385, 21706345, 21817123, 21831512, 21849373, 21860988, 21905086, 21962461, 21963104, 22288516, 22531952, 22542122, 22588140, 22674639, 22707004, 22816227, 22816871, 22840592, 23023996, 23036134, 23086134, 23160873, 23168606, 23306768, 23343798, 23350826, 23390832, 23443345, 23640005, 23659987, 23672520, 23796570, 23797521, 23861324, 24047061, 24183730, 24231837, 24258099, 24334159, 24382548, 24498480, 24666884, 24704117, 24711149, 24763155, 24763156, 24792229, 24971138, 25003921, 25073008, 25130167, 25266357, 25369726, 25377297, 25444700, 25920290, 26043913, 26054138, 26106616, 26142713, 26215431, 26362793, 26506165, 26663447, 26855795, 26883688, 26886884, 26921645, 26960195, 26978321, 27038769, 27059833, 27131966, 27438055, 27501593, 27636211, 27701661, 27871927, 27911988, 28153510, 28169458, 28248418, 28345778, 28346721, 28407338, 28417154, 28508398, 28655016, 28744557, 28801034, 28961380"
214,Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update,"KQ 1: In patients undergoing major orthopedic surgery (total hip or knee replacement, hip fracture surgery), what is the comparative efficacy between classes of thromboprophylaxis interventions on venous thromboembolism outcomes, treatment adherence, major bleeding, and other adverse events? KQ 2: In patients undergoing major orthopedic surgery (total hip or knee replacement, hip fracture surgery), what is the comparative efficacy of individual thromboprophylaxis interventions within classes (low molecular weight heparin, factor Xa inhibitors, direct thrombin inhibitors, and mechanical devices) on venous thromboembolism outcomes, treatment adherence, major bleeding, and other adverse events? KQ 3: In patients undergoing major orthopedic surgery (total hip or knee replacement, hip fracture surgery), what is the comparative efficacy of different doses, regimens, or treatment durations of the same thromboprophylaxis interventions (low molecular weight heparin, factor Xa inhibitors, direct thrombin inhibitors, and mechanical devices) on venous thromboembolism outcomes, treatment adherence, major bleeding, and other adverse events?
KQ 4 (update of original KQ 7 plus expansion): In patients undergoing major orthopedic surgery (total hip or knee replacement, hip fracture surgery), what is the comparative efficacy of combined classes of thromboprophylaxis interventions versus single classes on venous thromboembolism outcomes, treatment adherence, major bleeding, and other adverse events? KQ 5: In patients undergoing major orthopedic surgery (total hip or knee replacement, hip fracture surgery), based on network meta-analysis, what are the comparative effects of thromboprophylaxis interventions on deep vein thrombosis and, separately, major bleeding? 5.1: What are the comparative effects of different classes of thromboprophylaxis interventions? 5.2: What are the comparative effects of different individual thromboprophylaxis interventions? KQ 6: In patients undergoing major orthopedic surgery (total hip or knee replacement, hip fracture surgery), what is the comparative efficacy of starting pharmacologic thromboprophylaxis at different times (i.e., preoperative, intraoperative, postoperative) on venous thromboembolism outcomes, treatment adherence, major bleeding, and other adverse events?","(""Arthroplasty, Replacement, Knee""[Mesh] or (""Arthroplasty""[Mesh] AND (knee or hip)) or total knee replacement or knee arthroplasty or tkr or ""Knee Prosthesis""[Mesh] or knee prosthesis or knee joint or ""Arthroplasty, Replacement, Hip""[Mesh] or total hip replacement or hip arthroplasty or thr or ""Hip Prosthesis""[Mesh] or Hip Prosthesis or hip fracture surgery or hfs or ((""Fracture Fixation, Internal""[Mesh] or ""Fracture Fixation, Intramedullary""[Mesh]) AND (hip femur or femor* or tibia* or ankle or foot)) or (arthroscop* AND (knee or meniscectomy or synovectomy or cruciate ligament)) or ""Casts, Surgical""[Mesh] or surgical cast or plaster cast or splint* or ""Splints""[Mesh] or Achilles tendon or tibial plateau fracture or distal femur fracture or (lumbar AND (laminectomy or discectomy or fusion)) or (osteotomy AND (femur OR femor* OR tibia*))) AND (""Pulmonary Embolism""[Mesh] or pulmonary embol* or pulmonary thromboembol* or PE or deep vein thrombos* or deep venous thrombos* or deep venous thromboembol* or deep vein thromboembol* or DVT or ""Venous Thromboembolism""[Mesh] or venous thromboembol* or VTE or ""Venous Thrombosis""[Mesh] or venous thrombos* or clot) AND (""Anticoagulants""[Mesh] OR ""Aspirin""[Mesh] or aspirin or clopidogrel or ticlopidine or prasugrel or ""Heparin""[Mesh] or ""Heparinoids""[Mesh] or heparin or UFH or LMWH or enoxaparin or dalteparin or nadroparin or ardeparin or bemiparin or certoparin or parnaparin or reviparin or tinzaparin or danaparoid or fondaparinux or idraparinux or rivaroxaban or apixaban or enoxaparin or ""Hirudins""[Mesh] or desirudin or argatroban or bivalirudin or lepirudin or dabigatran or ""Warfarin""[Mesh] or warfarin or ""4-Hydroxycoumarins""[Mesh] or acenocoumarol or dicoumarol or ""Dextran Sulfate""[Mesh] or dextran sulfate or ""Stockings, Compression""[Mesh] or ((compression or elastic) AND (stocking* or boot*)) or GCS or venous foot pump or VFP or ""Intermittent Pneumatic Compression Devices""[Mesh] or pneumatic compression or pneumatic hose or pneumatic compression hose or IPC or ""Vena Cava Filters""[Mesh] or vena cava filter* or IVC or ""Factor Xa Inhibitors""[Mesh])","17473143, 20088935, 20194309, 20206776, 20589317, 20646562, 20652250, 20723033, 20797774, 20886185, 21175312, 21225098, 21284801, 21293896, 21348557, 21641758, 21934585, 22005861, 22058295, 22101618, 22429800, 22684546, 22713698, 22733945, 22738999, 22952213, 23381297, 23539696, 23566737, 23615791, 23732713, 23782955, 24136153, 24395322, 24408881, 24680549, 24695091, 24767296, 24931228, 25034972, 25047458, 25294589, 25436073, 25482425, 25511580, 25815018, 25831700, 25852131, 25963358, 26269694, 26735531, 26790579"
215,Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin,"Key Question 1: What is the comparative effectiveness of various interventions, overall and in subgroups of interest? Key Question 2: How do the adverse events associated with the various interventions compare overall and in subgroups of interest?","((""Bowen's Disease""[Mesh] OR bowen’s OR ""basal cell carcinoma"" OR ""basal cell carcinomas"" OR ""Carcinoma, Basal Cell""[Mesh] OR BCC OR ""squamous cell carcinoma"" OR ""squamous cell carcinomas"" OR ""Carcinoma, Squamous Cell""[Mesh] OR SCC OR ((keratinocyte* OR ""Keratinocytes""[Mesh]) AND (carcinoma* OR ""Carcinoma""[Mesh])) OR ""non-melanoma"" OR ""non melanoma"" OR ""nonmelanoma"") NOT (Oropharynx OR Oropharyngeal neoplasms OR ""Oropharyngeal Neoplasms""[Mesh] OR Pharynx OR Pharyngeal neoplasms OR ""Pharyngeal Neoplasms""[Mesh] OR ""Lung Neoplasms""[Mesh] OR ""Urinary Bladder Neoplasms""[Mesh] OR ""Uterine Cervical Neoplasms""[Mesh] OR ""Esophageal Neoplasms""[Mesh] OR ""Laryngeal Neoplasms""[Mesh])) AND (((Surger* OR surgic*) AND (excision OR removal)) OR ""shave removal"" OR ""external beam radiation"" OR ""external-beam radiation"" OR brachytherap* OR ""Brachytherapy""[Mesh] OR chemotherap* OR Sensus OR X-ray OR ""X-Ray Therapy""[Mesh] OR radiotherapy OR ""Radiotherapy""[Mesh] OR (topical AND (medications OR chemotherap*)) OR observation OR ""watchful waiting"" OR ((Mohs OR micrographic*) AND surgery) OR ""Mohs Surgery""[Mesh] OR Curett* OR ""Curettage""[Mesh] OR diathermy OR ""Diathermy""[Mesh] OR cauterization OR ""Cautery""[Mesh] OR Cryotherapy OR ""Cryotherapy""[Mesh] OR electrodesiccation OR ((CO2 OR ""carbon dioxide"") AND laser AND therapy) OR ""Laser Therapy""[Mesh] OR plesiotherapy OR ""Methyl 5-aminolevulinate"" OR ""methyl 5-aminolevulinate"" [Supplementary Concept] OR MALA OR ""5-aminolevulinic acid"" OR ""Aminolevulinic Acid""[Mesh] OR ALA OR Photodynamic OR ""Photochemotherapy""[Mesh] OR Photochemotherap* OR 5-fluorouracil OR 5-FU OR Methotrexate OR ""Methotrexate""[Mesh] OR Bleomycin OR ""Bleomycin""[Mesh] OR imiquimod OR ""imiquimod"" [Supplementary Concept] OR BEC-5 OR diclofenac OR ""Diclofenac""[Mesh] OR interferon OR IFN OR ""Ingenol mebutate"" OR ""3-ingenyl angelate"" [Supplementary Concept] OR PEP005 OR PEP-005 OR ""PEP 005"" OR Vismodegib OR Erivedge OR ""HhAntag691"" [Supplementary Concept] OR NSC747691 OR NSC-747691 OR ""NSC 747691"" OR R-3616 OR R3616 OR ""R 3616"" OR RG-3616 OR RG3616 OR ""RG 3616"" OR GDC-0449 OR GDC0449 OR ""GDC 0449"" OR Sonidegib OR Odomzo OR ""LDE225"" [Supplementary Concept] OR NVP-LDE225 OR Itraconazole OR ""Itraconazole""[Mesh] OR Sporanox OR Orungal OR R51211 OR R-51211 OR ""R 51211"")","298425, 1430394, 2107219, 2229497, 2383027, 3514075, 8708151, 8977678, 8996264, 9218740, 10570388, 10845311, 10940063, 11069453, 11298545, 11312429, 12196749, 12224977, 12452875, 12653747, 14725659, 14732655, 15097956, 15377935, 15541449, 15606733, 15888150, 16393600, 16490846, 16713457, 16785375, 16865869, 17301830, 17451581, 17573890, 17610993, 17875873, 18624836, 18693158, 18717680, 19010733, 19018814, 19438672, 19588534, 20064185, 20546215, 21242584, 21576572, 22145798, 22385074, 22511036, 22738399, 23190903, 23566745, 23566914, 23683751, 23725586, 24102369, 24139468, 24332516, 24903544, 25047438, 25066012, 25262378, 25899562, 25913533, 25981810, 26157307, 26551044, 26589877, 26985197, 27067393, 27067394, 27113429, 27516420, 27932240, 28199463, 28365039"
216,Long-Term Health Outcomes in Obstructive Sleep Apnea: A Systematic Review of Comparative Studies Evaluating Positive Airway Pressure and Validity of Breathing Measures as Surrogate Outcomes,"KQ 1: What is the efficacy, effectiveness, comparative effectiveness, and harms of CPAP devices to improve long-term health outcomes? 
KQ 1a: How are respiratory disturbance events (apnea, hypopnea, arousal) defined in each study? What are the diagnostic criteria for OSA (or criteria to treat with CPAP) in each study? How do the diagnostic criteria relate to time of the AASM criteria? Do treatment effects of CPAP differ by the specific diagnostic criteria used within or across studies? 
KQ 1b: What is the within-study concordance in CPAP trials among apnea and hypopnea indices (e.g., apnea-hypopnea index [AHI], apnea index), sleep questionnaires (e.g., Epworth Sleepiness Scale [ESS]), and long-term health outcomes?*
KQ 1c: Do the health effects or harms of specific CPAP devices differ by patient subgroups, duration of followup, or particular CPAP features?
KQ 1d: Summarize the methodological issues in the existing studies.
KQ 2: What is the evidence that apnea and hypopnea-based measures of sleep-disordered breathing (e.g., apneic indices, hypopnea indices, and apnea-hypopnea indices) used in current practice and research are valid surrogate or intermediate measures for long-term health outcomes?
KQ 2a: Summarize the methodological issues in the existing studies. What is the ideal study design for establishing the validity of a surrogate or intermediate measure?","((((Apnea* OR Hypopnea*) AND sleep) OR sleep-disordered breathing OR ""Sleep Apnea, Obstructive""[Mesh] OR ""Airway Resistance""[Mesh] OR ""Snoring""[Mesh] OR Upper airway resistance syndrome* OR Respiratory disturbance* OR obstructive sleep apnea* OR obstructive sleep apnoea* OR snore OR snoring OR hypoxia) NOT ((""Sleep Apnea, Central""[Mesh] OR ""Obesity Hypoventilation Syndrome""[Mesh] OR ""Parkinson Disease""[Mesh] OR ""Down Syndrome""[Mesh] OR ""Prader-Willi Syndrome""[Mesh] OR ""Congenital Abnormalities""[Mesh] OR ""Epilepsy""[Mesh] OR ""Narcolepsy""[Mesh]) NOT ""Sleep Apnea, Obstructive""[Mesh])) AND (""Positive-Pressure Respiration""[Mesh] OR ""Continuous Positive Airway Pressure""[Mesh] OR Continuous Positive Airway Pressure OR ""Intermittent Positive-Pressure Ventilation""[Mesh] OR ""Ventilators, Mechanical""[Mesh] OR mask* OR ""Masks""[Mesh] OR mechanical ventilator* OR respirator Or respirators OR CPAP machine OR Polysomnography OR ""Polysomnography""[Mesh] OR ((apnea-hypopnea AND (score OR index)) OR ""Respiratory effort-related arousal"" OR ""Respiratory effort related arousal"" OR ""respiratory disturbance index"" OR Apnea* OR Hypopnea*) AND (cardiovascular OR cerebrovascular OR mortality OR death OR CVD OR blood pressure OR diabetes OR hypertension OR stroke OR ""quality of life"" OR ""cognitive function"" OR cognition* OR traumatic injury* OR depression OR anxiety OR ""substance use disorder"" OR ""mental health"" OR ""health status"" OR ""Epworth Sleepiness Scale"" OR ""Functional Outcomes Sleep Questionnaire"" OR (accident* AND (""motor vehicle"" or car or traffic)) OR ""Cardiovascular Diseases""[Mesh] OR ""Multiple Sleep Latency Test"" OR ""Maintenance of Wakefulness Test"" OR ""General Health Questionnaire"" OR ""Calgary sleep apnea quality of life index"" OR ""Paced Auditory Serial Addition Test"" OR ""Sleep Apnea Syndromes/complications""[Mesh] OR ""Blood Pressure""[Mesh] OR ""Mortality""[Mesh] OR ""Death""[Mesh] OR ""Diabetes Mellitus""[Mesh] OR ""Hypertension""[Mesh] OR ""Quality of Life""[Mesh] OR ""Wounds AND Injuries""[Mesh] OR ""Accidents, Traffic""[Mesh] OR ""Cognition""[Mesh] OR ""Anxiety""[Mesh] OR ""Depression""[Mesh] OR ""Mental Health""[Mesh] OR ""Substance-Related Disorders""[Mesh]))","10712335, 10805822, 11300121, 11587974, 16735919, 17561541, 17638595, 18663661, 19958890, 20646611, 21804670, 22499826, 22562077, 22618923, 23088487, 23111478, 23204602, 23620682, 23766914, 24452812, 24458949, 24508706, 25125635, 25172769, 25205641, 25412159, 25431105, 25669180, 25700873, 25766707, 25914563, 26063688, 26068440, 26763030, 26856225, 26914592, 26926656, 26993342, 27018174, 27198943, 27571048, 28083705, 28225159, 28294380, 28419387, 28550476, 28561345, 28636405, 28735924, 28823814, 28913630, 28947040, 28982804, 29045745, 29152745, 29582703, 29773460, 29800001, 29808422, 30130421, 30848437, 30973594, 31116848, 31193555, 31312807, 31538602, 31596213, 31839558, 32029279, 32421898, 32665778, 33729910"
217,Tympanostomy Tubes in Children With Otitis Media,"Question 1: For children with chronic otitis media with effusion, what is the effectiveness of tympanostomy tubes, compared to watchful waiting, on resolution of middle ear effusion, hearing and vestibular outcomes, quality of life and other patient-centered outcomes?
a.	What factors (such as age, age of onset, duration of effusion, comorbidities, and sociodemographic risk factors) predict which children are likely to benefit most from the intervention?
b.	Does obtaining a hearing test help identify which children are more likely to benefit from the intervention?
Question 2: For children with recurrent acute otitis media, what is the effectiveness of tympanostomy tubes, compared to watchful waiting with episodic or prophylactic antibiotic therapy, on the frequency and severity of otitis media, quality of life, and other patient centered-outcomes? What factors (such as age, age of onset, number of recurrences, presence of persistent middle ear effusion, comorbidities, and sociodemographic risk factors, history of complications of acute otitis media, antibiotic allergy or intolerance) identify children who are most likely to benefit from the intervention?
Question 3: What adverse events, surgical complications, and sequelae are associated with inserting tympanostomy tubes in children with either chronic otitis media with effusion or recurrent acute otitis media?
Question 4: Do water precautions reduce the incidence of tympanostomy tube otorrhea, or affect quality of life?
Question 5: In children with tympanostomy tube otorrhea, what is the comparative effectiveness of topical antibiotic drops versus systemic antibiotics or watchful waiting on duration of otorrhea, quality of life, or need for tube removal?","(otitis OR ""glue ear"" OR ""Otitis Media with Effusion""[Mesh] OR ""Otitis Media, Suppurative""[Mesh] OR ""Ear, Middle/secretion""[Mesh] OR (middle AND ear AND (effusion* or infect* or inflame* or disease*)) OR ((OME OR SOM or AOM) AND (otitis OR ear)) OR ((mucoid* AND middle AND ear) OR (mucous AND middle AND ear) OR (seromuc* AND middle AND ear))) AND (tympanostomy OR grommet* OR ((ear or ""pressure equalization"" or PE or myringotomy or ventilating or ventilation) AND (tube or tubes)) OR ""Otitis Media with Effusion/surgery""[mesh] OR ""Middle Ear Ventilation""[Mesh] OR ((middle AND (ear OR tympanic)) AND (tube or tubes)) OR ""Otologic Surgical Procedures""[Mesh] OR T-tube or tubulation)","321716, 456299, 576016, 985199, 1169745, 1267356, 1267359, 1267702, 1431515, 1485779, 1565550, 1565551, 1742892, 1816937, 1861917, 2070526, 2128487, 2181158, 2239252, 2396808, 2492178, 2645490, 2789777, 3128752, 3177616, 3336263, 3372141, 3427802, 3472335, 3472336, 3537596, 3570884, 3586818, 3683478, 3780019, 3799183, 3814387, 4039792, 4040147, 4040338, 4105168, 4215997, 4702615, 6184891, 6470572, 6526581, 6538215, 6541254, 6613541, 6778334, 6778336, 6819525, 7192477, 7195446, 7543180, 8024107, 8085732, 8179266, 8195687, 8231117, 8246466, 8289048, 8436453, 8607955, 8745020, 8877228, 9118580, 9176804, 9225174, 9287928, 9350484, 9372253, 9738746, 10187945, 10190709, 10190921, 10208683, 10326811, 10406312, 10435125, 10459904, 10546304, 10547462, 10591365, 10807325, 10865480, 10944051, 10969126, 11124783, 11271428, 11309632, 11309633, 11389239, 11409855, 11470387, 11551611, 11735817, 11797262, 12150521, 12161732, 12220208, 12578443, 12690269, 12728089, 12759263, 12897272, 12930655, 14660913, 14702493, 15126745, 15195060, 15224825, 15231974, 15373863, 15533143, 15689760, 15837895, 15837896, 15992470, 15995051, 16093466, 16094135, 16151352, 16156910, 16214225, 16330739, 16406076, 16429748, 16446953, 16510637, 16773972, 16880248, 17049144, 17178938, 17229952, 17279052, 17465378, 17582514, 18047760, 18565598, 18594333, 18722211, 19251534, 19260880, 19324425, 19715725, 19819563, 19929085, 20399511, 20979100, 21205368, 21397957, 22183900, 22386274, 22443163, 22466327, 22648089, 22796197, 22883987, 23119801, 23120310, 23737350, 23855103, 23874870, 24265883, 24303379, 24445832, 24552319, 24627408, 25171763, 25465449, 25598389, 25724629, 25764097, 25896832"
218,Management of Colonic Diverticulitis,"KQ 1: In CT imaging for the diagnosis or staging of acute diverticulitis,
KQ 1a. What is the test accuracy of CT imaging for the diagnosis or staging of acute diverticulitis?
KQ 1b. What are the effects of CT imaging on clinical outcomes and changes in clinical management?
KQ 1c. What are the downstream outcomes related to false positive or false negative CT readings of acute uncomplicated or complicated diverticulitis
KQ 1d. For patients presenting with acute abdominal pain, with the possibility of acute diverticulitis, what are the downstream outcomes related to incidental findings (e.g., liver mass)
•	Does the accuracy or do the effects vary by patient characteristics, presentation of illness, or other factors? 
KQ 2: What are the benefits and harms of various treatment options for the treatment of acute diverticulitis?
KQ 2a. For patients with acute uncomplicated diverticulitis, what are the effectiveness and harms of hospitalization versus outpatient management of the acute episode? 
•	Do the effects and harms vary by patient characteristics, presentation or course of illness, or other factors?
KQ 2b. For patients with acute uncomplicated or complicated diverticulitis, what are the effects, comparative effects, and harms of antibiotics? 
•	Do the effects and harms vary between patients with complicated or uncomplicated diverticulitis?
•	Do the (comparative) effects and harms vary by route of administration of antibiotics, type of antibiotic, and duration of course of antibiotics? 
•	Do the (comparative) effects and harms vary by patient characteristics, presentation or course of illness, or other factors?
KQ 2c. For patients with acute complicated diverticulitis, what are the effects and harms of interventional radiology procedures compared with conservative management?
•	Do the effects and harms vary by patient characteristics, presentation or course of illness, or other factors?
KQ 3: What are the benefits and harms of colonoscopy (or other colon imaging test) following an episode of acute diverticulitis? 
KQ 3a. What is the incidence of malignant and premalignant colon tumors found by colonoscopy, and what is the incidence of colon cancer mortality among patients undergoing screening?
KQ 3b. What are the procedure-related and other harms of colonoscopy or CT colonography?
KQ 3c. What is the frequency of inadequate imaging due to intolerance or technical feasibility?
•	Do the benefits and harms vary by patient characteristics, course of illness, or other factors?
KQ 4: What are the effects, comparative effects, and harms of pharmacological interventions (e.g., mesalamine), non-pharmacological interventions (e.g., medical nutrition therapy), and elective surgery to prevent recurrent diverticulitis? 
•	Do the (comparative) effects and harms vary by patient characteristics, course of illness, or other factors? ","((((""Diverticulitis""[Mesh] OR ""Diverticulosis, Colonic""[Mesh] OR diverticulitis [tiab] OR diverticulosis [tiab] OR diverticular [tiab] OR ""Abdomen, Acute""[Mesh] OR ""acute abdomen"" OR ((acute or nonspecific OR non-specific OR emergen*) AND (abdome* OR abdomi*) AND pain) OR peritonitis) AND (""Tomography, X-Ray Computed""[Mesh] OR CT scan OR ""cat scan"" OR tomography OR ""low dose CT"" OR LDCT OR ""Spiral CT"")) OR ((""Diverticulitis""[Mesh] OR ""Diverticulosis, Colonic""[Mesh] OR diverticulitis [tiab] OR diverticulosis [tiab] OR diverticular [tiab]) AND (Hospital OR hospitals OR hospitalization OR ""Hospitalization""[Mesh] OR Inpatient* OR discharge* OR outpatient OR ""Ambulatory Care""[Mesh] OR antibiotic* OR ""Anti-Bacterial Agents""[Mesh] OR medication* OR medical OR ""Radiology, Interventional""[Mesh] OR interventional radiology))) OR ((""Diverticulitis""[Mesh] OR ""Diverticulosis, Colonic""[Mesh] OR diverticulitis [tiab] OR diverticulosis [tiab] OR diverticular [tiab]) AND (Colonoscopy OR Colonography OR ""Colonography, Computed Tomographic""[Mesh] OR ""Colonoscopy""[Mesh] OR ((colon OR colorectal) AND (cancer or carcinoma or neoplasm*) AND screen*) OR ((colon OR colorectal) AND ""Early Detection of Cancer""[Mesh]) OR (""Colonic Neoplasms""[Mesh] AND screen*)))) OR ((""Diverticulitis""[Mesh] OR ""Diverticulosis, Colonic""[Mesh] OR ""Diverticulosis, Small Intestinal"" [Supplementary Concept] OR diverticulitis[tiab] OR diverticulosis[tiab] OR diverticular[tiab]) AND (Recur* OR repet* OR repeat OR attacks OR ""Elective Surgical Procedures""[Mesh] OR Mesalazine OR Mesalamine OR ""Mesalamine""[Mesh] OR 5-ASA OR ""5 ASA"" OR Aminosalicylic Acid OR Pentacol OR ""Diet Therapy""[Mesh] OR diet OR fiber OR fibre OR rifaximin OR ""Probiotics""[Mesh] OR probiotic* OR balsalazide OR VSL#3 OR Lactobacillus casei OR ((surger* OR surgic* OR resect* OR operation OR operate) AND elective)))","1638578, 12236485, 14639493, 16108882, 17190761, 17390144, 17554647, 17883294, 18639223, 19016815, 20140619, 20193685, 20484998, 20526718, 20812161, 20878256, 21346548, 21689302, 21732208, 21904141, 21979190, 22290281, 22706731, 23092785, 23171930, 23636075, 23701063, 23732265, 23754545, 23764519, 24105001, 24178863, 24475484, 24723071, 25038431, 25083288, 25472747, 25576049, 25773308, 25960972, 26116319, 26125459, 26275534, 26378691, 26490053, 26541732, 27120447, 27170283, 27422847, 27686365, 27941344, 28035461, 28241291, 28387885, 28404008, 28528364, 28543263, 28664347, 29663068, 29679152, 29683483, 29700480, 29808306, 29900742, 29916880, 29945147, 30247329, 30335195, 30527478, 30566245, 30632029, 30747633, 30807455, 30878216, 31043657, 31267222, 31290747, 31320921"
219,Management of Primary Headache During Pregnancy,"KQ 1: What are the (comparative) benefits and harms of interventions to prevent attacks of primary headache in women who are pregnant (or attempting to become pregnant), postpartum, or breastfeeding? 
KQ 1a. Do the (comparative) benefits and harms vary by phase (i.e., preconception, first trimester of pregnancy, second trimester of pregnancy, third trimester of pregnancy, postpartum, breastfeeding)?
KQ 1b. Do the (comparative) benefits and harms vary by type of primary headache (i.e., migraine, tension headache, cluster headache, and other trigeminal autonomic cephalgias)?

KQ 2: What are the (comparative) benefits and harms of interventions to treat acute attacks of primary headache in women who are pregnant (or attempting to become pregnant), postpartum, or breastfeeding? 
KQ 2a. Do the (comparative) benefits and harms vary by phase (i.e., preconception, first trimester of pregnancy, second trimester of pregnancy, third trimester of pregnancy, postpartum, breastfeeding)?
KQ 2b. Do the (comparative) benefits and harms vary by type of primary headache (i.e., migraine, tension headache, cluster headache, and other trigeminal autonomic cephalgias)?","(""Breast Feeding""[Mesh] OR ""Fertilization""[Mesh] OR ""Gestational age""[Mesh] OR ""Lactation""[Mesh] OR ""Maternal Behavior""[Mesh] OR ""Maternal exposure""[Mesh] OR ""Maternal-Fetal Exchange""[Mesh] OR ""Perinatal Care""[Mesh] OR ""Pregnancy""[Mesh] OR ""pregnancy complications""[Mesh] OR ""pregnancy trimesters""[Mesh] OR breastfeeding OR ""fetal growth"" OR ""gestational age"" OR postpartum OR pregnancy OR pregnant OR trimester OR lactation OR polycystic ovary syndrome OR IVF OR ""In Vitro Fertilization"" OR insemination OR ""Polycystic Ovary Syndrome""[Mesh] OR ""Fertilization in Vitro""[Mesh]) AND (Migraine OR ""Migraine Disorders""[Mesh] OR ""Tension-Type Headache""[Mesh] OR ""Cluster Headache""[Mesh] OR headache OR ""Headache Disorders, Primary""[Mesh] OR ((tension OR cluster) AND headache))","25415168, 10728620, 24598456, 29569251, 19804390, 26525300, 25644494, 29723901, 27625061, 20132339, 21751829, 28758416, 11318881, 8682668, 23884894, 10759898, 8600478, 22946832, 2401622"
220,Cognitive stimulation to improve cognitive functioning in people with dementia,"To evaluate the effectiveness and impact of cognitive stimulation interventions aimed at improving cognition for people with dementia, including any negative effects",((Dementia[Mesh] OR Delirium[Mesh] OR Wernicke Encephalopathy[Mesh] OR Delirium OR Dementia OR Amnestic OR Cognitive Disorders[Mesh] OR dement* OR alzheimer* OR lewy body OR  deliri* OR chronic cerebrovascular OR organic brain disease or organic brain syndrome OR (normal pressure hydrocephalus AND shunt*) OR  benign senescent forgetfulness OR Cerebr* deteriorat* OR cerebral* insufficient* OR pick* disease OR creutzfeldt or jcd or cjd OR huntington* OR  binswanger* OR korsako*) AND (cognitiv* OR reality orientation OR memory therapy OR memory group* OR memory support OR memory stimulat* OR global stimulation OR cognitive psycho-stimulation or cognitive psychostimulation OR Psychomotor Performance[Mesh])),12948999 15084794 15603468 16260821 16323385 16738349 21483095 22468985 22495338 22573599 24052800 24676963 25525349 25528281 25656505 27497474 28222815 29781725 30370782 31930518 32252544 32881071 33089699 33104028 33140499 33437991 35012439 35221680
221,Accelerated diagnostic protocols that use high-sensitivity troponin assays to “rule in” or “rule out” myocardial infarction,"KQ 1: Among adults presenting to the ED with suspected acute coronary syndrome, what are the effectiveness and comparative effectiveness of ADPs that use hs-cTn on clinical and health service use outcomes. KQ 2: What are the clinical and health service use outcomes among adults presenting to the ED with suspected acute coronary syndrome who have indeterminant (“grey” or “observational” zone) results of ADPs that use hs-cTn?","((((""Chest Pain""[Mesh] OR ""Myocardial Ischemia""[Mesh] OR ""Acute Coronary Syndrome""[Mesh] OR ""Myocardial Infarction""[Mesh] OR (acute coronary syndrome*[tiab]) OR (preinfarc*[tiab] AND Angina*[tiab]) OR (pre-infarc*[tiab] AND Angina*[tiab]) OR ""Unstable angina*""[tiab] OR ((heart*[tiab] OR myocardi*[tiab] OR cardiac[tiab] OR coronary[tiab]) AND (preinfarc*[tiab] OR infarc*[tiab] OR attack*[tiab] OR arrest*[tiab] OR occlusion*[tiab] OR ischemia*[tiab] OR ischaemia[tiab]) OR occlusi*[tiab]) OR MI[tiab] OR ACS[tiab] OR STEMI[tiab] OR NSTE-ACS[tiab] OR NSTEACS[tiab] OR nonSTEMI[tiab] OR NSTEMI[tiab] OR AMI[tiab] OR UAP[tiab] OR OMI[tiab] OR ((acute[tiab] OR ischem*[tiab] OR ischaem*[tiab]) AND (coronar*[tiab] OR cardiac*[tiab] OR heart[tiab])) OR ((heart[tiab] OR myocard*[tiab]) AND infarct*[tiab]))) AND ((""troponin T""[Mesh] OR ""troponin I""[Mesh] OR troponin[Mesh] OR ""trop I""[tiab] OR ""trop t""[tiab] OR ""troponin I""[tiab] OR ""troponin T""[tiab] OR accu-tni[tiab] OR accutni[tiab] OR ctni-hs[tiab] OR ctni-ultra[tiab] OR ctni[tiab] OR ctnihs[tiab] OR ctnt-hs[tiab] OR ctnt[tiab] OR cTnT[tiab] OR ctnths[tiab] OR hs-ctni[tiab] OR hs-cTnT[tiab] OR hs-tni[tiab] OR hs-TnT[tiab] OR hsctni[tiab] OR hscTnT[tiab] OR Hstni[tiab] OR hsTnT[tiab] OR tni[tiab] OR tnt-hs[tiab] OR tnt[tiab] OR tnths[tiab] OR tropI[tiab] OR troponin*[tiab] OR tropT[tiab] OR ""Accelerated diagnostic protocol*"" OR ""HEART Pathway"" OR ""EDACS-ADP"" OR ""EDACS"" OR ADP))) AND ((""Emergency Service, Hospital""[Mesh] OR emergency room* OR emergency department* OR ED OR ER OR ""Triage""[Mesh] OR ""Emergencies""[Mesh] OR ""Emergency Responders""[Mesh] OR ""Emergency Treatment""[Mesh] OR ""Emergency Medicine""[Mesh] OR ""Emergency Medical Technicians""[Mesh] OR ""Emergency Medical Services""[Mesh] OR ""Ambulances""[Mesh] OR ""Hospital Rapid Response Team""[Mesh] OR triage OR emergenc* OR ambulance* OR EMT OR EMS OR ""Cardiology Service, Hospital""[Mesh]))) ","35571147, 34824100, 34423355, 33753972, 33752439, 33662739, 33436490, 32320036, 31623760, 30661856, 30249382, 29478861, 26947800, 26387473, 25499373, 22594354, 22291171"
222,Protocols to Reduce Seclusion in Inpatient Mental Health Units: A Systematic Review,"KQ 1: What protocols have been described to reduce seclusion practices for adult patients in inpatient mental health units? 1.1: What are the described resource needs (such as personnel and space needs) of these protocols? KQ 2: What are the comparative effects of protocols to reduce seclusion practices on resource use, staff and unit practices, patient experiences, and staff experiences versus usual protocols?","(""Mental Disorders""[Mesh] OR ""Psychiatry""[Mesh] OR ""Hospitals, Psychiatric""[Mesh] OR ""Mental Health""[Mesh] OR mental[tiab] OR mentally[tiab] OR psychiatr*[tiab] OR schizophren*[tiab] OR psychoti*[tiab]) AND (""Coercion""[Mesh] OR ""Patient Isolation""[Mesh] OR ""Commitment of Mentally Ill""[Mesh] OR Coerci*[tiab] OR Seclusion[tiab] OR Patient Isolation[tiab] OR Patient Immobili*[tiab] OR Compulsor*[tiab] OR Mentally Ill Commitment*[tiab] OR Involuntary Commitment*[tiab] OR (involunta*[tiab] NOT movement*[tiab]) OR ((lock[tiab] OR locked[tiab] OR locking[tiab] OR contained[tiab] OR containment*[tiab]) AND (door[tiab] OR doors[tiab] OR ward[tiab] OR wards[tiab] OR room[tiab] OR rooms[tiab]))) AND (Prevent* OR avoid* OR deter* OR delay*)","22549524, 18700217, 22016437, 20712684, 31206989, 15534024, 36006571, 32391731, 26897657, 20349887, 22439145, 26166187, 24548312, 28372555, 23890418, 32691495, 19291492, 17102932, 35650555, 8936879, 11901660, 27845534, 17890979, 18844799, 32749904, 10565060, 29331599, 8444440, 26820456, 25751828, 23014117, 24305908"
223,"Lower Limb Prostheses: Measurement Instruments, Comparison of Component Effects by Subgroups, and Long-Term Outcomes","The following summarized Key Questions (KQs) are addressed by the review: KQ 1. What assessment techniques used to measure functional ability of adults with major lower limb amputation have been evaluated in the published literature? KQ 2. What prediction tools used to predict functional outcomes in adults with major lower limb amputation have been evaluated in the published literature? KQ 3. What functional outcome measurement tools used to assess adults who use an LLP have been evaluated in the published literature? KQ 4. In adults who use a lower limb prosthesis, how do ambulatory, functional, and patient-centered outcomes with different prosthetic components vary based on study participant characteristics? KQ 5. How do study participants’ preprescription expectations of ambulation align with their functional outcomes? KQ 6. What is the level of patient satisfaction with the process of accessing an LLP (including experiences with both providers and payers)? KQ 7. At 6 months, 1 year, and 5 years after receipt of an LLP, (accounting for intervening mortality, subsequent surgeries, or injuries) what percentage of individuals…? i. Maintain bipedal ambulation ii. Use their prostheses only for transfers iii Use prostheses only indoors iv. Have abandoned their prostheses v. Have major problems with prosthesis","(""Recovery of Function""[Mesh] OR ""functional assessment"" OR ""functional status"" OR “Mobility Limitation”[Mesh] OR function OR mobility OR ambulation OR stair* OR locomotion OR “treatment outcome” OR walking OR (abandonment AND prosthe*) OR (rejection* AND prosthe*) OR Quality of Life OR Health Status) AND (“Artificial limb” OR “Artificial limbs” OR ""Artificial Limbs""[Mesh] OR prosthe* OR Artificial Limbs) AND (""Lower Extremity""[Mesh] OR “leg”[Mesh] or lower extremity or foot or ankle or tibia or fibula or femur or thigh or “Membrum inferius” or leg or lower limb)","11994800, 22042373, 25917819, 27770064, 18724135, 11588750, 10954097, 14727699, 2235304, 21310896, 23856150, 26637652, 12227445, 22424695, 8831480, 28862042, 27496697, 14682557, 27590443, 28866959, 12648004, 22389424, 21947182, 26874230, 25944625, 15295762, 15129396, 12809197, 24997811, 15129395, 15129398, 9710165, 21704978, 20809056, 11588757, 17351696, 15497923, 25450484, 21684165, 18566922, 12851094, 20489393, 18050010, 15180125, 15982169, 25134533, 16466153, 12422326, 15558399, 21568057, 27828871, 25768067, 21303214, 15077637, 21807149, 10378500, 25588644, 7991366, 17520493"
224,Short and Long Term Outcomes after Bariatric Surgery in the Medicare Population,"KQ 1: What are the theorized mechanisms of action of bariatric surgery on various health outcomes in the Medicare population? KQ 2: In studies that are applicable to the Medicare population and enroll patients who have undergone bariatric surgery, what are (a) the characteristics of the patients including descriptives of age, BMI, and comorbid conditions (b) the characteristics of the interventions, including pre-surgical work-ups (e.g., psychiatric evaluations, behavioral and nutritional counseling), surgical procedures, and postsurgical support (e.g., psychiatric, behavioral and nutritional counseling) and (c) the outcomes that have been measured, including peri-operative (i.e., 90 days or less after bariatric surgery), short-term (2 years or less from surgery), mid-term (more than 2 but 5 or less years), and long-term (more than 5 years after surgery) outcomes? KQ 3a: In Medicare-eligible patients, what is the effect of different bariatric surgery procedures (contrasted between them or vs. non-surgical interventions) on weight outcomes (including failure to achieve at least minimal weight loss)? KQ 3b: What patient- (KQ2a) and intervention-level factors (KQ2b) modify the effect of surgical interventions on weight outcomes (including failure to achieve at least minimal weight loss)? KQ 3c: In Medicare-eligible patients who have undergone bariatric surgical interventions, what is the frequency and the predictors of failing to achieve at least minimal weight loss?","(""Anastomosis, Roux-en-Y""[Mesh] OR ""anti obesity procedure” OR ""anti obesity surgery” OR ""Gastric Balloon""[Mesh] OR ""Gastroenterostomy""[Mesh] OR “anti-obesity procedure” OR “anti-obesity procedures” OR “anti-obesity surgery“ OR “Aspiration therapy” OR “balloon system” OR “bariatric operation”  OR “bariatric operations”  OR “bariatric procedure” OR “bariatric procedures” OR “bariatric surgeries” OR “bariatric surgery”  OR ""Bariatric Surgery""[Mesh] OR “biliopancreatic bypass” OR “biliopancreatic diversion” OR ""Biliopancreatic Diversion""[Mesh]  OR “collis gastroplasty” OR “Duodenal mucosal resurfacing” OR “duodenal switch” OR “Duodenojejunal bypass sleeve” OR “Endoluminal vertical gastroplasty” OR “gastric balloon” OR “gastric band” OR “gastric banding” OR “gastric bands” OR “gastric bypass” OR ""Gastric Bypass""[Mesh] OR “gastric greater curvature plication” OR “gastric imbrication” OR “gastric pacing” OR “gastric plication” OR “gastric procedure” OR “gastric procedures” OR “gastric sleeve” OR “gastric staple” OR “gastric stapling” OR “Gastric stimulation” OR “Gastroduodenojejunal bypass sleeve” OR “gastroileal bypass” OR “gastroileal bypass” OR “gastrointestinal diversion”  OR “gastrointestinal procedure” OR “gastrointestinal procedures” OR “gastrointestinal surgeries” OR “gastrointestinal surgery” OR “Gastroplasty”[Mesh] OR “horizontal banded” gastroplasty OR “ileojejunal bypass” OR “intestinal bypass” OR “intragastric balloon”  OR “intragastric band” OR “intragastric bypass” OR “intragastric sleeve” OR “jejuno ilial bypass” OR “jejuno-ilial bypass” OR “jejunoileal bypass” OR “Jejunoileal Bypass”[Mesh]  OR “lap band” OR “lap banding” OR “lap bands” OR “laparoscopic adjustable gastric banding” OR “realize band” OR “restrictive bypass” OR “restrictive procedure” OR “restrictive procedures” OR “restrictive surgeries” OR “restrictive surgery” OR “Self-assembling magnets” endoscopy OR “silicon band” OR “silicon banding” OR “silicon bands” OR “Single Anastomosis Duodeno-Ileostomy” OR “sleeve gastrectomy”  OR “stomach band”  OR “stomach banding” OR “stomach bands” OR “stomach bypass” OR “stomach stapling” OR “Swedish band” OR “transpyloric shuttle” OR “Vagal blockade” OR “vertical banded gastroplasty” OR “vertical-banded gastroplasty” OR aspireassist OR gastroenterostomy OR gastrogastrostomy OR gastrojejunostom* OR gastroplasties OR gastroplasty OR malabsorpti* procedure OR malabsorpti* surgery OR omentectomy OR “Omentum removal” OR roux-en-y)
(""Anastomosis, Roux-en-Y""[Mesh] OR ""anti obesity procedure"" OR ""anti obesity surgery"" OR ""Gastric Balloon""[Mesh] OR ""Gastroenterostomy""[Mesh] OR ""anti-obesity procedure"" OR ""anti-obesity procedures"" OR ""anti-obesity surgery"" OR ""Aspiration therapy"" OR ""balloon system"" OR ""bariatric operation"" OR ""bariatric operations"" OR ""bariatric procedure"" OR ""bariatric procedures"" OR ""bariatric surgeries"" OR ""bariatric surgery"" OR ""Bariatric Surgery""[Mesh] OR ""biliopancreatic bypass"" OR ""biliopancreatic diversion"" OR ""Biliopancreatic Diversion""[Mesh] OR ""collis gastroplasty"" OR ""Duodenal mucosal resurfacing"" OR ""duodenal switch"" OR ""Duodenojejunal bypass sleeve"" OR ""Endoluminal vertical gastroplasty"" OR ""gastric balloon"" OR ""gastric band"" OR ""gastric banding"" OR ""gastric bands"" OR ""gastric bypass"" OR ""Gastric Bypass""[Mesh] OR ""gastric greater curvature plication"" OR ""gastric imbrication"" OR ""gastric pacing"" OR ""gastric plication"" OR ""gastric procedure"" OR ""gastric procedures"" OR ""gastric sleeve"" OR ""gastric staple"" OR ""gastric stapling"" OR ""Gastric stimulation"" OR ""Gastroduodenojejunal bypass sleeve"" OR ""gastroileal bypass"" OR ""gastroileal bypass"" OR ""gastrointestinal diversion"" OR ""gastrointestinal procedure"" OR ""gastrointestinal procedures"" OR ""gastrointestinal surgeries"" OR ""gastrointestinal surgery"" OR ""Gastroplasty""[Mesh] OR ""horizontal banded"" gastroplasty OR ""ileojejunal bypass"" OR ""intestinal bypass"" OR ""intragastric balloon"" OR ""intragastric band"" OR ""intragastric bypass"" OR ""intragastric sleeve"" OR ""jejuno ilial bypass"" OR ""jejuno-ilial bypass"" OR ""jejunoileal bypass"" OR ""Jejunoileal Bypass""[Mesh] OR ""lap band"" OR ""lap banding"" OR ""lap bands"" OR ""laparoscopic adjustable gastric banding"" OR ""realize band"" OR ""restrictive bypass"" OR ""restrictive procedure"" OR ""restrictive procedures"" OR ""restrictive surgeries"" OR ""restrictive surgery"" OR ""Self-assembling magnets"" endoscopy OR ""silicon band"" OR ""silicon banding"" OR ""silicon bands"" OR ""Single Anastomosis Duodeno-Ileostomy"" OR ""sleeve gastrectomy"" OR ""stomach band"" OR ""stomach banding"" OR ""stomach bands"" OR ""stomach bypass"" OR ""stomach stapling"" OR ""Swedish band"" OR ""transpyloric shuttle"" OR ""Vagal blockade"" OR ""vertical banded gastroplasty"" OR ""vertical-banded gastroplasty"" OR aspireassist OR gastroenterostomy OR gastrogastrostomy OR gastrojejunostom* OR gastroplasties OR gastroplasty OR malabsorpti* procedure OR malabsorpti* surgery OR omentectomy OR ""Omentum removal"" OR roux-en-y)","18239641, 26264895, 27063637, 18830777, 24913586, 21870049, 25814071, 24582414, 20490708, 17138231, 26864395, 24318411, 26091994, 27795883, 21459686, 26220238, 27220823, 15479593, 19760975, 25239175, 23733390, 15946437, 27279392, 25859266, 28039650, 25088486, 23636997, 22508671, 15603658, 22648797, 24304479, 20532834, 25832986, 27179771, 17400516, 25708829, 18071836, 16477271, 25373923, 24442420, 25929176, 26201412, 22234587, 23700235, 24708912, 25868831, 19705206, 25519772, 25573879, 24570089, 22551574, 21975317, 26243345, 15273547, 23344504, 17938305, 22000180, 19517199, 26220241, 17331804, 19277799, 16234496, 25824474, 15941878, 17576885, 24927691, 24913590, 24519024, 23604694, 26428251"
225,Strategies for Improving the Lives of Women Aged 40 and Above Living with HIV/AIDS,"In Area 1 we grouped guiding questions that pertain to measuring the impact of strategies for engaging with resources that aim to enhance the wellbeing of aging women who live with HIV/AIDS or barriers to engaging with such resources. In Area 2 we grouped questions about measuring the impact of insurance on women’s well-being. In Area 3 we grouped questions about the diagnosis or management of comorbidities, or the role of comorbidities in predicting all-cause mortality or HIV-related disease progression.","(older or “middle age” or “middle aged” or “middle-age” or “middle-aged” or ""Middle Aged""[Mesh] OR ""Aged""[Mesh] or elderly or post-menopause or postmenopause or ""Postmenopause""[Mesh]) AND (HIV or ""HIV""[Mesh] or “Human immunodeficiency virus” or ""HIV Infections""[Mesh] or (“Acquired Immunodeficiency Syndrome”) or ""Acquired Immunodeficiency Syndrome""[Mesh]) AND (women or female or ""Women""[Mesh])","15607387, 15664714, 15688281, 15735456, 15812611, 15875183, 15890044, 15914552, 15916493, 15986873, 15989436, 16019998, 16041896, 16044016, 16053402, 16088365, 16117747, 16170757, 16232053, 16238507, 16251820, 16254546, 16258865, 16271919, 16280699, 16311491, 16340472, 16364566, 16475891, 16475893, 16494629, 16511419, 16548714, 16550266, 16575739, 16604295, 16630034, 16639542, 16652320, 16673835, 16702714, 16706615, 16706709, 16711309, 16770290, 16770694, 16789855, 16813512, 16816559, 16827627, 16838244, 16840235, 16847590, 16909323, 16914390, 16943224, 16954726, 16970600, 16979403, 17030018, 17065131, 17084795, 17091022, 17099312, 17113345, 17133204, 17148967, 17166077, 17192148, 17194480, 17209696, 17224844, 17243069, 17284499, 17316873, 17328657, 17333382, 17349451, 17415113, 17428185, 17428189, 17436074, 17446833, 17447147, 17453589, 17491177, 17503172, 17514382, 17546496, 17561878, 17563286, 17563291, 17563293, 17570298, 17584813, 17589194, 17594252, 17652642, 17659577, 17662571, 17675724, 17712763, 17721095, 17768674, 17786561, 17828761, 17852582, 17855466, 17879926, 17931064, 17935929, 17943043, 17950469, 17971562, 17971712, 17978868, 17983336, 17984744, 18046634, 18077833, 18089980, 18089983, 18089984, 18095166, 18154490, 18176319, 18190326, 18191769, 18193497, 18197121, 18260805, 18263847, 18278624, 18285714, 18293137, 18320045, 18329222, 18331632, 18332290, 18338961, 18389363, 18432391, 18441253, 18457763, 18483850, 18486266, 18494840, 18540736, 18580614, 18596682, 18620492, 18626764, 18627280, 18669717, 18672562, 18677078, 18677084, 18692034, 18701730, 18760524, 18770023, 18777131, 18794720, 18796158, 18799777, 18806878, 18823189, 18844464, 18854330, 19001104, 19003664, 19008505, 19013829, 19050396, 19054631, 19055408, 19056866, 19072715, 19110909, 19125548, 19127438, 19131891, 19133752, 19142824, 19154859, 19166089, 19203845, 19229685, 19229695, 19234779, 19282781, 19372524, 19387832, 19430305, 19441980, 19444661, 19505589, 19521925, 19555288, 19576548, 19609624, 19645619, 19653047, 19682102, 19694550, 19710335, 19742170, 19753412, 19803793, 19847637, 19887771, 19909501, 19911481, 19921420, 19925308, 19937504, 19949848, 19996978, 20023215, 20048680, 20059570, 20078196, 20098331, 20099954, 20101190, 20118830, 20124207, 20135214, 20146111, 20151840, 20161771, 20167995, 20168013, 20173648, 20205279, 20210646, 20367803, 20391059, 20397898, 20408389, 20450418, 20502393, 20509050, 20521408, 20526793, 20534139, 20552469, 20597691, 20605046, 20622678, 20626193, 20626901, 20638118, 20640593, 20653483, 20661839, 20675952, 20698966, 20703792, 20711651, 20716711, 20740376, 20799975, 20824549, 20827218, 20832196, 20845112, 20846009, 20857188, 20859159, 20861396, 20921898, 20922510, 20940199, 20946441, 20950406, 20963630, 20969465, 20976538, 21042930, 21116186, 21139489, 21145198, 21146004, 21160411, 21165692, 21189273, 21191643, 21208772, 21214376, 21244204, 21248273, 21251183, 21284498, 21297425, 21302180, 21317590, 21339382, 21341962, 21345624, 21346587, 21372250, 21375430, 21376083, 21399478, 21400307, 21423852, 21443312, 21450595, 21452051, 21457056, 21488749, 21503833, 21526398, 21667297, 21669958, 21685547, 21705396, 21725250, 21749845, 21777141, 21781946, 21784531, 21809048, 21811144, 21813622, 21831304, 21877252, 21885212, 21890753, 21900636, 21911892, 21925831, 21937921, 21955175, 21960715, 22011239, 22012149, 22042879, 22067661, 22085330, 22098257, 22112600, 22115794, 22149765, 22223813, 22246513, 22263299, 22265144, 22272732, 22296865, 22308010, 22313955, 22324292, 22328294, 22350832, 22422679, 22471341, 22510354, 22528619, 22530794, 22534149, 22545737, 22547872, 22547876, 22547877, 22563020, 22592587, 22594352, 22623771, 22643464, 22643470, 22648011, 22675242, 22697293, 22698023, 22719814, 22731500, 22732470, 22734850, 22736272, 22739396, 22762716, 22766967, 22767342, 22770948, 22792882, 22797951, 22820790, 22828593, 22828718, 22854158, 22860900, 22866506, 22870846, 22871482, 22879972, 22942209, 22955429, 22956397, 22965693, 22968399, 22983536, 22994175, 23020136, 23023657, 23025248, 23050767, 23054036, 23065532, 23075914, 23079809, 23080359, 23086427, 23108721, 23111573, 23121723, 23128979, 23138877, 23143526, 23143751, 23148715, 23161210, 23180286, 23204161, 23208648, 23224290, 23242158, 23244367, 23250298, 23265919, 23277897, 23288378, 23311323, 23332770, 23334359, 23335641, 23337369, 23340238, 23358784, 23382948, 23386631, 23388678, 23392459, 23396734, 23419804, 23430708, 23432593, 23446088, 23450876, 23456594, 23474642, 23494224, 23515640, 23528143, 23551395, 23555868, 23555970, 23570481, 23584606, 23595542, 23605401, 23625127, 23631790, 23636311, 23644816, 23651103, 23651105, 23664855, 23669157, 23673792, 23698680, 23704120, 23715264, 23725449, 23760634, 23768670, 23780395, 23797695, 23802143, 23812892, 23829330, 23835502, 23873217, 23874575, 23890194, 23921611, 23921612, 23934269, 23947744, 23975476, 23982662, 23991690, 24000053, 24022091, 24056066, 24065316, 24065317, 24070644, 24085706, 24093810, 24112091, 24126447, 24135776, 24138486, 24141487, 24220684, 24237482, 24256631, 24271348, 24274688, 24286128, 24286967, 24287787, 24325326, 24330207, 24332577, 24334180, 24368003, 24377076, 24378603, 24384803, 24400124, 24432878, 24438679, 24450279, 24463281, 24464408, 24493009, 24525448, 24533631, 24549970, 24554483, 24558098, 24580808, 24592813, 24606220, 24625234, 24630628, 24637542, 24643444, 24668254, 24670522, 24674234, 24714446, 24726429, 24745475, 24752996, 24755037, 24770984, 24801492, 24845948, 24870935, 24872131, 24983302, 25000260, 25005803, 25015912, 25032989, 25036553, 25038354, 25041708, 25043931, 25065513, 25081100, 25091306, 25114132, 25123240, 25139373, 25150257, 25151662, 25153084, 25173116, 25201556, 25202921, 25211714, 25225233, 25251326, 25301208, 25314249, 25324353, 25329710, 25387450, 25407085, 25458205, 25467560, 25469520, 25469916, 25491946, 25503739, 25559604, 25559605, 25567825, 25588033, 25600199, 25665013, 25695849, 25706092, 25706232, 25714794, 25772053, 25826007, 25848927, 25853590, 25874644, 25892019, 26009831, 26077242, 26120890, 26181704, 26181705, 26196502"
226,Interventions for Substance Use Disorders in Adolescents: A Systematic Review,"Key Question 1. What are the effects of behavioral, pharmacologic, and combined interventions compared with placebo or no active treatment for substance use disorders and problematic substance use in adolescents to achieve abstinence, reduce quantity and frequency of use, improve functional outcomes, and reduce substance-related harms? 1a. How do benefits and adverse outcomes of interventions vary by subpopulations? 1b. How do benefits and adverse outcomes of interventions vary by intervention characteristics. Key Question 2. What are the comparative effects of active interventions for substance use disorders and problematic substance use in adolescents to achieve abstinence, reduce quantity and frequency of use, improve functional outcomes, and reduce harms? 2a. How do comparative benefits and adverse outcomes of interventions vary by subpopulations? 2b. How do comparative benefits and adverse outcomes of interventions vary by intervention characteristics?","(((“Juvenile Delinquency/rehabilitation”[MeSH Terms] OR (juvenile AND (offender* or delinquency or prison)) OR (""Substance-Related Disorders""[Mesh] NOT (""Substance-Related Disorders/prevention AND control""[Mesh] NOT ""Substance-Related Disorders""[Mesh])) OR “drug offense” OR “Drug abuse” OR “drug misuse” OR “drug dependence” OR “drug addiction” OR “substance use” OR “substance abuse” OR “substance misuse” OR “substance dependence” OR “substance addiction” OR “prescription abuse” OR “Alcoholism”[Mesh] OR “cannabis use disorder” OR “alcohol use disorder” OR “stimulant use disorder” OR “hallucinogen use disorder” OR “opioid use disorder” OR “inhalant use disorder”) OR  ((Alcohol OR “Alcoholic Beverages”[Mesh] OR cannabis OR Marijuana OR “Cannabis”[Mesh] OR “Marijuana Abuse”[Mesh] OR “Marijuana Smoking”[Mesh] OR opioids OR “Narcotics”[Mesh] OR “Analgesics, Opioid”[Mesh] OR kratom OR hallucinogens OR “Psychotropic Drugs”[Mesh] OR inhalants OR toluene OR ((amyl OR butyl OR isobutyl) AND nitrites) OR stimulants OR “Central Nervous System Stimulants”[Mesh] OR “Amphetamines”[Mesh] OR Sedatives OR “Hypnotics AND Sedatives”[Mesh] OR Benzodiazepines OR “Benzodiazepines”[Mesh] OR Anthramycin OR Bromazepam OR Clonazepam OR Devazepide OR Diazepam OR Flumazenil OR Flunitrazepam OR Flurazepam OR Fentanyl OR Alprazolam OR Clonidine OR Hashish Clonidine OR Lorazepam OR Nitrazepam OR Oxazepam OR Pirenzepine OR Prazepam OR Temazepam OR Chlordiazepoxide OR Clorazepate Dipotassium OR Estazolam OR Medazepam OR Midazolam OR Triazolam OR opioid* OR opiate* OR Heroin OR opium OR “Morphine Derivatives”[Mesh] OR Codeine OR Hydrocodone OR Oxycodone OR Dihydromorphine OR Ethylmorphine OR Heroin OR Hydromorphone OR Morphine OR Oxymorphone OR Thebaine OR Cocaine OR “Cocaine”[Mesh] OR Methamphetamine* OR “Methamphetamine”[Mesh] OR Benzphetamine OR anabolic steroids OR “Testosterone Congeners”[Mesh] OR antihistamines OR nitrous oxide OR betel nut OR kava OR Ecstasy OR phenylalkylamines OR mescaline OR 2,5-dimethoxy-4-methylamphetamine OR MDMA  OR 3,4-methylenedioxymethamphetamine OR indoleamine* OR psilocybin  OR psilocin OR dimethyltryptamine  OR ergoline* OR lysergic acid diethylamide OR “morning glory seeds” OR “Salvia divinorum”  OR jimsonweed OR anxiolytic OR benzodiazepine* OR zolpidem OR zaleplon OR carbamate* OR glutethimide OR meprobamate OR barbiturate*  OR secobarbital OR barbiturate*  OR glutethimide  OR methaqualone OR amphetamine OR dextroamphetamine OR methamphetamine OR gabapentin OR baclofen OR diacetylmorphine OR kratom OR polydrug OR “poly-drug” OR polysubstance OR “poly-substance” OR “injection drug”) AND (addict* OR abus* OR misus* OR disorder* OR mis-use OR dependen*))) AND (“Telemedicine/methods”[Mesh] OR “Active aftercare” OR “Adolescent Community Reinforcement Approach” OR “Alcoholics Anonymous” OR “Narcotics Anonymous” OR “12-step” OR “assertive community treatment” OR “assertive continuing care”  OR “Behavior Therapy”[Mesh] OR “brief intervention” OR “brief interventions” OR “Brief negotiated interview” OR “brief strategic family therapy” OR “Buprenorphine, Naloxone Drug Combination”[Mesh]  OR “Buprenorphine”[Mesh]  OR “Cognitive behavioral therapy” OR “Cognitive Therapy” OR “Cognitive-behavioral therapy” OR “Cognitive-behavioral treatment” OR “Combined Modality Therapy”[Mesh] OR “Contingency management” OR “Culturally Informed AND Flexible Family-Based Treatment for Adolescents” OR “culturally-based intervention” OR “delinquency-treatment programs” OR “dopaminergic agent” OR “drug counseling” OR “Dual diagnosis therapy” OR “Dual diagnosis treatment” OR “Dual Recovery Therapy” OR “Family Therapy”[Mesh] OR “glutaminergic agent” OR “group therapy” OR “Harm reduction” OR “Interpersonal process groups” OR “Matrix-Model” OR “medication assisted treatment” OR “Methadone”[Mesh] OR “Motivational Enhancement Therapy” OR “Motivational incentives” OR “motivational interview” OR “motivational interviewing” OR “Motivational Interviewing”[Mesh] OR “Multidimensional Treatment Foster Care”  OR “Multisystemic Therapy”  OR “mutual help group” OR “Naloxone”[Mesh] OR “Narcotic Antagonists”[Mesh]) OR “Opioid replacement” OR “Opioid substitution” OR “oral THC” OR “Phoenix Academy” OR “Recovery Coach” OR “Recovery High School” OR “Reinforcement-based” OR “Seeking Safety” OR “Self-Help for Alcohol AND Other Drug Use AND Depression” OR “seven challenges” OR “Skills development groups” OR “Substance Abuse Program” OR “synthetic cannabinoids” OR “synthetic opioid” OR “systemic Therapy” OR “Teen Marijuana Check-Up” OR “Therapy, Computer-Assisted”[Mesh] OR ((family OR psychosocial OR Psychoeducational) AND (therapy or therapies or treatment* or intervention* or counseling)) OR (behavior* AND (intervention* OR modification*)) OR A-CRA OR Acamprosate OR Acomplia OR amiodarone OR Buprenorphine OR Bupropion OR Cannabidiol OR CIFFTA OR citalopram OR dexamfetamine OR dexamphetamine OR Disulfiram OR duloxetine OR escitalopram OR fluoxetine OR gabapentin OR lisdexamfetamine  OR Lithium OR Long-acting injectable OR meditation OR Methadone OR mindfulness OR Nabiximols OR Naltrexone OR paroxetine OR Peer-based OR “peer support” OR pemoline OR Pharmacological interventions OR prazosin OR pregabalin OR quetiapine OR Rimonabant OR Sativex OR SBIRT OR sertraline OR Topiramate  OR varenicline OR venlafaxine OR Vilazodone ) AND (adolescent [MeSH] OR adolescen* OR teen* OR young people OR young person* OR young adult* OR youth* OR girl OR girls OR boy OR boys OR juvenile* OR ""Young Adult""[Mesh])","7862806, 8610836, 9473913, 9824170, 10365191, 10596521, 11258740, 11680557, 11727882, 12108813, 12127465, 12371576, 12436013, 12554608, 12957348, 14678061, 15152709, 15187802, 15194207, 15343198, 15385223, 15501373, 15501373, 15784061, 15878048, 15896928, 16095844, 16102378, 16203961, 16279281, 16551142, 16771893, 16822119, 16858633, 16928395, 16938063, 16989957, 17182419, 17182420, 17182429, 17207126, 17453612, 17563146, 17600651, 17869051, 17984403, 18037603, 18072842, 18266532, 18665684, 18705691, 18778385, 18978635, 18984887, 19042328, 19170450, 19298659, 19320697, 19321268, 19470315, 19522781, 19553067, 19717250, 19948382, 20053238, 20156957, 20180674, 20219293, 20307791, 20393347, 20473370, 20494267, 20576364, 20670329, 20873891, 21169172, 21170166, 21383276, 21411243, 21440994, 21513687, 21531089, 21609157, 21639636, 21684088, 21688877, 21834613, 21868186, 21871372, 21885210, 21967492, 22000326, 22004303, 22024000, 22107875, 22154039, 22299805, 22309470, 22560728, 22706327, 22866693, 22889694, 22931079, 23054350, 23140805, 23228436, 23438248, 23489253, 23528523, 23795871, 23811060, 23891459, 23895403, 23958035, 24166335, 24485347, 24491069, 24841864, 24955669, 24969735, 25222484, 25242878, 25247027, 25328373, 25382960, 25462653, 25496283, 25551562, 25602465, 25621927, 25642126, 25736623, 25742208, 25799306, 25981755, 26004659, 26213796, 26234955, 26347440, 26362000, 26389639, 26415058, 26454835, 26654213, 26690291, 26752416, 26827257, 26879671, 26890999, 26918564, 26992083, 27120317, 27220276, 27454353, 27568507, 27577862, 27629581, 27690505, 27762569, 27801991, 27875802, 27929312, 27936376, 28287800, 28414474, 28476263, 28742932, 28886575, 28930060, 29252011, 29424802, 29750362, 29866383, 29871891, 30140308, 30589350, 31067018"
227,Prehabilitation and Rehabilitation for Major Joint Replacement,"KQ 1: What are the effects, comparative effects, and harms of (preoperative) prehabilitation services (and specific components) for patients with osteoarthritis undergoing elective, unilateral, total knee replacement surgery on patient-reported outcomes, performance-based outcomes, and healthcare utilization? KQ 2: What are the effects, comparative effects, and harms of (postoperative) rehabilitation services (and specific components) for patients with osteoarthritis undergoing elective, unilateral, total knee replacement surgery on patient-reported outcomes, performance-based outcomes, and healthcare utilization? KQ 3: What are the effects, comparative effects, and harms of (preoperative) prehabilitation services (and specific components) for patients with osteoarthritis undergoing elective, unilateral, total hip replacement surgery on patient-reported outcomes, performance-based outcomes, and healthcare utilization? KQ 4: What are the effects, comparative effects, and harms of (postoperative) rehabilitation services (and specific components) for patients with osteoarthritis undergoing elective, unilateral, total hip replacement surgery on patient-reported outcomes, performance-based outcomes, and healthcare utilization?","((arthroplast* or hip replacement* or knee replacement* or joint replacement* or total hip or total knee or total joint*) OR ""Arthroplasty, Replacement, Hip""[Mesh] OR ""Arthroplasty, Replacement, Knee""[Mesh] OR ((""Arthroplasty""[Mesh] or arthroplasty or replacement) and (knee or hip))) AND ((pre-hab* or prehab*) OR ""Arthroplasty, Replacement, Knee/rehabilitation""[Mesh] OR ""Arthroplasty, Replacement, Hip/rehabilitation""[Mesh]OR ((presurg* or preoperativ* or pre-surg* or pre-operativ* or early or home) and (rehab or rehabilitate or rehabilitation or re-hab* or ""Rehabilitation""[Mesh] or ""Physical Therapy Modalities""[Mesh] or ""physical therapy"" or physiotherapy*)) OR (""Preoperative Care/methods""[Mesh] OR ""Preoperative Care/rehabilitation""[Mesh] ) OR ((before or prior to) and (arthroplast* or hip replacement* or knee replacement* or joint replacement* or total hip or total knee or total joint*) and (rehab or rehabilitate or rehabilitation or re-hab* or intervention* or recovery)) OR ((""Preoperative Care""[MESH] OR ""Preoperative Period""[MESH]) and (rehab or rehabilitate or rehabilitation or re-hab* or ""Rehabilitation""[Mesh] or ""Physical Therapy Modalities""[Mesh] or ""physical therapy"" or physiotherapy*)) OR (""Postoperative Period""[Mesh] and (rehab or rehabilitate or rehabilitation or re-hab*)) OR ((postsurg* or post-surg* or postoperativ* or post-operativ*) AND (rehab or rehabilitate or rehabilitation or re-hab* or ""Rehabilitation""[Mesh] or ""Physical Therapy Modalities""[Mesh] or ""physical therapy"" or physiotherapy*)) OR ((after or post) AND (arthroplast* or hip replacement* or knee replacement* or joint replacement* or total hip or total knee or total joint*) AND (rehab or rehabilitate or rehabilitation or re-hab* or ""Rehabilitation""[Mesh] or ""Physical Therapy Modalities""[Mesh] or ""physical therapy"" or physiotherapy*)))","30021552, 28899328, 31003647, 29352683, 29372260, 28419032, 29529614, 26713665, 25925404, 23641782, 22170790, 26239078, 25305374, 30794296, 26474988, 22196125, 20360503, 27068368, 31033232, 27296366, 19876883, 29493347, 31977324, 31208916, 27295978, 28291891, 24341348, 26178888, 27529575, 32026820, 28254734, 20354057, 21080347, 21398389, 29473481, 31101039, 27813347, 24241606, 23412304, 23063624, 18499950, 30782304, 21410130, 21630176, 23661494, 26355656, 22180446, 26768606, 28217891, 31687984, 17604311, 30994586, 28119232, 22914302, 29294078, 26996450, 16942627, 19695525, 23651717, 24459172, 22095207, 17768187, 27868384, 30361758, 22643801, 19177536, 23614370, 28506775, 23474735, 26763947, 19177542, 23271039, 15869558, 17013852, 31723080, 27810379, 27455419, 22480863, 19282040, 25552523, 33051212, 24484541, 20533147, 32373475, 32360105, 32488010, 32778907, 33863614"
228,Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review,"1. What is the efficacy or association of n-3 FA (EPA, DHA, EPA+DHA, DPA, SDA, ALA, or total n-3 FA) exposures in reducing CVD outcomes (incident CVD events, including all-cause death, CVD death, nonfatal CVD events, new diagnosis of CVD, peripheral vascular disease, CHF, major arrhythmias, and hypertension diagnosis) and specific CVD risk factors (BP, key plasma lipids)? What is the efficacy or association of n-3 FA in preventing CVD outcomes in people Without known CVD (primary prevention), At high risk for CVD (primary prevention), and With known CVD (secondary prevention)? What is the relative efficacy of different n-3 FA on CVD outcomes and risk factors? Can the CVD outcomes be ordered by strength of intervention effect of n-3 FA?  How does the efficacy or association of n-3 FA in preventing CVD outcomes and with CVD risk factors differ in subpopulations, including men, premenopausal women, postmenopausal women, and different age or race/ethnicity groups? What are the effects of potential confounders or interacting factors—such as plasma lipids, body mass index, BP, diabetes, kidney disease, other nutrients or supplements, and drugs (e.g.,
statins, aspirin, diabetes drugs, hormone replacement therapy)? What is the efficacy or association of different ratios of n-3 FA components in dietary supplements or biomarkers on CVD outcomes and risk factors? How does the efficacy or association of n-3 FA on CVD outcomes and risk factors differ by ratios of different n-3 FA—DHA, EPA, and ALA, or other n-3 FA? How does the efficacy or association of n-3 FA on CVD outcomes and risk factors differ by source (e.g., fish and seafood, common plant oils (e.g., soybean, canola), fish oil supplement, fungal-algal supplements, flaxseed oil supplements)? How does the ratio of n-6 FA to n-3 FA intakes or biomarker concentrations affect the efficacy or association of n-3 FA on CVD outcomes and risk factors? Is there a threshold or dose-response relationship between n-3 FA exposures and CVD outcomes and risk factors? Does the study type affect these relationships?  How does the duration of intervention or exposure influence the effect of n-3 FA on CVD outcomes and risk factors? What is the effect of baseline n-3 FA status (intake or biomarkers)
on the efficacy of n-3 FA intake or supplementation on CVD outcomes and risk factors? What adverse effects are related to n-3 FA intake (in studies of
CVD outcomes and risk factors)? What adverse events are reported specifically among people with CVD or diabetes (in studies of CVD outcomes and risk factors)?","(“fatty acids, omega-3”[Mesh] OR ((omega-3 or omega 3 or omega3) and fatty acid*) OR “fatty acids, essential”[Mesh] OR “linolenic acids”[Mesh] OR “fish oils”[Mesh] OR ((n 3 or n3 or n-3) and (oil or pufa or fatty acid or omega 3)) OR “Docosahexaenoic Acids”[Mesh] OR docosahexaenoic OR docosapentaenoic OR “Eicosapentaenoic Acid”[Mesh] OR eicosapentaenoic OR icosapentaenoic OR (alpha linolenic or alphalinolenic or alpha-linolenic) OR (linolenate or cervonic or timnodonic or stearidonic) OR menhaden oil OR ((flax or flaxseed or flax seed or linseed or rape seed or rapeseed or canola or soy or soybean or walnut or mustard seed or perilla or shiso) AND oil) OR (walnut* or butternut* or soybean* or pumpkin seed*) OR (fish oil) OR (cod liver oil or codliver oil or marine oil or marine fat) OR (salmon or mackerel or herring or tuna or halibut or seaweed or anchov* or sardine*) OR (Ropufa or MaxEPA or Omacor or Efamed or ResQ or Epagis or Almarin or Coromega or Lovaza or Vascepa or icosapent ethyl) OR (fish consumption or fish intake or (fish diet*)) OR (mediterranean diet*) OR ((red blood cell or phospholipid or plasma fatty acid or plasma or phospholipid or triacylglycerol or cholesteryl or ester or adipos* or fatty acid or erythrocyte or ghost or platelet or granulocyte or neutrophil or mononuclear or LDL or HDL) and (DHA or docosahexaenoic or docosapentaenoic or EPA or eicosapentaenoic or SDA or linolenic or stearidonic or omega))) AND (“cardiovascular diseases”[Mesh] OR atherosclero* OR Arteriosclero* OR cardioprotect* OR Coronary OR heart disease* OR Myocardial infarct* OR “Cerebrovascular Accident” OR stroke OR (Transient Ischemic Attack or TIA) OR “lipids”[Mesh] OR lipid* OR “cholesterol”[Mesh] OR cholesterol OR “Lipoproteins, LDL”[Mesh] OR “Lipoproteins, HDL”[Mesh] OR “triglycerides”[Mesh] OR triglycerides OR “Hyperlipidemias”[Mesh] hypertriglyceridem* OR hyperlipidemia* OR “dyslipidemias”[Mesh] OR dyslipidemia* OR “blood pressure”[Mesh] OR blood pressure OR (diastole* or systole* or mean arterial) OR “hypertension”[Mesh] OR hypertension OR “Hemorrhage”[Mesh] OR hemorrhag* OR bleeding OR ""Myocardial Infarction""[MeSH] OR heart attack OR ""Heart Failure""[MeSH] OR “heart failure” OR CHD OR atrial fibrillation OR afib OR ""Acute Coronary Syndrome""[Mesh] OR ACS OR cardiovascular OR ""Coronary Artery Disease""[MeSH])","17398308, 18757090, 10465168, 23098619, 17343767, 25226826, 24964401, 22265275, 22686415, 22172525, 20332801, 20929341, 20713915, 19064523, 21099130, 20211329, 23656645, 24496442, 21205024, 21610249, 12495393, 22365647, 11176840, 21734059, 25159901, 7598116, 9665096, 21561620, 11682363, 23945170, 18779276, 24343844, 23183517, 23839902, 21859970, 22952185, 25394692, 11939867, 22802735, 10189324, 19061714, 21844082, 21215550, 23920478, 22707560, 24351702, 19589110, 23546563, 24468152, 23788668, 22570739, 22146511, 19825219, 24528690, 24966412, 22743310, 7852747, 22633188, 23998969, 16301356, 24553695, 20484828, 21801476, 21115589, 22496770, 21464993, 15630029, 22819432, 16469978, 16401768, 17825687, 19383731, 16569549, 25147070, 19593941, 9149659, 25008580, 24267237, 7829792, 22811376, 19397392, 7885425, 19933935, 18786479, 23525429, 8540453, 19789394, 25565485, 25185754, 22301766, 22894911, 21810709, 23265344, 22282329, 20451686, 9424039, 21865334, 16267249, 18614742, 19595382, 24360762, 16926660, 25122648, 18492834, 18451347, 24454276, 25679993, 15640459, 23047296, 23725919, 10578215, 24829493, 12032650, 7759696, 20335635, 21345851, 20389249, 20362710, 24462043, 12663273, 8021472, 24314359, 21060071, 15853118, 2571009, 15297084, 17876196, 11451717, 9174486, 12847992, 11997274, 20938439, 24126178, 24652053, 19002433, 1579579, 5756076"
229,Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer,"Key Questions (KQs). 1. Does regular aspirin use in patients without known cardiovascular disease (CVD) reduce CVD- and colorectal cancer (CRC) incidence and mortality, or all-cause mortality? a. Does the effect vary in specific a priori populations defined by age, sex, 10-year cardiovascular risk, race and ethnicity, or diagnosis of diabetes mellitus? b. Does the effect vary by dose or duration of aspirin use? 2. Does regular aspirin use increase major GI bleeding, intracranial bleeding, or other serious harms? a. Does the effect vary in specific a priori populations defined by age, sex, 10-year cardiovascular risk, diagnosis of diabetes mellitus, race and ethnicity, or bleeding risk factors? b. Does the effect vary by dose or duration of aspirin use? Data Sources and Search","(Aspirin[tiab] OR acetylsalicylic[tiab] OR Salicylate*[tiab]) AND (((colorectal[tiab] OR colon[tiab] OR colonic[tiab] OR rectal[tiab] OR rectum[tiab] OR rectosigmoid*[tiab]) AND (cancer[tiab] OR cancers[tiab] OR cancerous[tiab] OR carcinoma*[tiab] OR malignan*[tiab] OR tumor[tiab] OR tumoro*[tiab] OR tumors[tiab] OR tumour*[tiab] OR neoplasm*[tiab] OR polyp OR polypo* OR polyps[tiab])) OR stroke[tiab] OR cerebrovascular disease*[tiab] OR cerebrovascular disorder*[tiab] OR brain infarction*[tiab] OR cerebral infarction*[tiab] OR artery infarction*[tiab] OR “coronary thrombosis”[tiab] OR “coronary occlusion”[tiab] OR “cardiogenic shock”[tiab] OR “myocardial reperfusion”[tiab] OR “myocardial stunning”[tiab] OR “lateral medullary syndrome”[tiab] OR cardiovascular disease*[tiab] OR heart disease*[tiab] OR coronary disease*[tiab] OR vascular disease*[tiab] OR ""myocardial infarction""[tiab] OR “cardiac arrest”[tiab] OR ""heart arrest""[tiab] OR heart attack*[tiab] OR ""myocardial ischemia""[tiab] OR ""myocardial ischaemia""[tiab] OR ""coronary artery disease""[tiab] OR “acute coronary syndrome”[tiab] OR angina[tiab] OR “coronary restenosis”[tiab] OR “coronary stenosis”[tiab])",30146931 27296091 29111960 18927173 1783914 17499602 20970847 2664509 11483080 12034583 12034583 8331682 12939216 9556464 20197530 30158069 9635947 7866597 8535554 9360003 10826567 10875825 8193735 12409970 11403365 8193735 25401325 30565155 27165949 30046729 30221597 30023457 30221595 28329340 30221596 18637782 29111960 18997198 21515838 29909377 21270185 27881565 23778008 22447019 3125882 17499602 20970847 15753114 19815293 23856681 22090661 10718501 11197445 16418466 14633812 1682734 20970847 9457092 10875825 20970847 30146931 27296091 29111960 18927173 28449186 22706834 23604419 2664509 11483080 12034583 12034583 8331682 12939216 9556464 20197530 30158069 9635947 7866597 8535554 9360003 10826567 10875825 8193735 12409970 11403365 8193735 21209949 21320500 21531232 10471421 2061978 25401325 30565155 27165949 30046729 31755069 30366771 30221597 30023457 30221595 28329340 30221596 18637782 18997198 24042256 21270185 27881565 23778008 22447019 3125882 15753114 19815293 23856681 22090661 17938390 10718501 11197445 16418466 14633812 4633812 8330469 9457092 10875825 1514166